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ABSTRACT 
THE EFFECTS OF GROWTH HORMONE ON PRIMARY BOVINE MAMMARY 
CELL MODELS 
 
Lisa McDonnell 
 
 The ability of exogenous growth hormone (GH) to increase milk yield through 
insulin-like growth factor-1 (IGF-I) in dairy cows is well characterized.  However, recent 
studies utilizing mammary epithelial cell lines indicate a direct effect of GH on mammary 
epithelial cells (MEC).  To test if these observations are relevant in vivo and if this 
response differs between dairy breeds, three mammary models were utilized.  Mammary 
explants from a lactating Jersey cow were cultured in classical lactogenic media 
(dexamethasone, insulin, and prolactin) with 0 or 10 ng/mL of recombinant bovine GH 
for 12h.  Primary MEC from lactating Holstein and Jersey cows were cultured in classical 
lactation media with 0 or 10 ng/mL of GH for 2, 4, and 7 days.  And lastly, MEC isolated 
from pooled Holstein or pooled Jersey milk were cultured in the same conditions as 
primary MEC.  The response to GH was quantified by the relative abundance of mRNA 
for two milk protein genes (α-lactalbumin and αS1-casein), the GH receptor, IGF-I and 
insulin-like growth factor binding protein-3 (IGFBP-3) as determined by quantitative RT-
PCR.  The abundance of α-lactalbumin mRNA in explants was increased in response to 
GH.  After 2 days, Jersey primary MEC showed an increase in GH receptor mRNA, in 
addition to a noteworthy trend of increasing abundance of IGFBP-3 regardless of GH 
treatment.  After 4 days, Holstein primary cells cultured with GH had decreased IGFBP-3 
mRNA.  After 7 days, primary cells isolated from Holstein and Jersey mammary tissue 
showed a slight response to GH. Mammary cells from milk mirrored the responses to GH 
observed in primary cells: MEC isolated from Holsteins had decreased IGFBP-3 mRNA 
after 4 days of treatment with GH and MEC isolated from Jerseys showed the same trend 
of increasing IGFBP-3 abundance between 2 and 4 days, but with no difference between 
GH treatments.  These results indicate that the effect of GH may differ between breeds 
and indicate GH has a direct effect on mammary epithelial cells, possibly including 
effects on the abundance of IGFBP-3 mRNA. 
Keywords: mammary, primary cells, growth hormone, IGF-I, IGFBP-3   
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CHAPTER 1 
LITERATURE REVIEW 
The Mammary Gland 
The mammary gland is a secretory organ unique to the class Mammalia.  The 
mammary gland synthesizes and secretes the components of milk, which provides 
nutrition to their young.  Milk is a complete and easily digestible nutrient source, 
providing all of the necessary nutrients for growth including proteins, sugars, lipids, 
vitamins, and minerals.  In addition to nutrients, milk also provides immunological 
components, such as immunoglobulins and white blood cells, which aid in protecting the 
neonate from disease (Schmidt, 1971; Larson & Smith, 1974).  All of these components 
are secreted into the gland’s complex duct system for storage and eventual ejection. 
The mammary gland undergoes four distinct stages of development: 
mammogenesis, lactogenesis, galactopoiesis, and involution.  The development of the 
mammary gland is a continual process because the gland is capable of proliferation, 
differentiation, and involution many times throughout the adult life of the female animal.  
Each stage of development is directed by a unique hormonal milieu.  Estrogens, growth 
hormone (GH), progesterone, prolactin, insulin, and glucocorticoids all have a role in the 
development, function, and regression of the mammary gland which will be described in 
this section.   
Structure  
The form of the mammary gland differs by species, with some having breasts, 
rows of teats, or udders.  Each type of mammary gland has unique characteristics.  The 
breast is type of mammary gland found in humans and non-human primates.  Breasts, in 
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particular, are usually two symmetric glands and are thoracically located.  The structure 
of the mammary glands of canines, pigs, and rodents is markedly different from an udder.  
Mammary glands in these species can be more numerous (1-9 pairs of glands) and are 
located along the ventral side of the animal and teats are located from the thoracic region 
through the inguinal region.  Additionally, species with breasts or rows of teats have 
significantly less connective tissue, though the structure of alveoli and ductal systems 
remain similar (Sheffield, 1988).  Ruminants, such as cattle, sheep and goats, exemplify 
the udder mammary structure.   
The udder is comprised of a secretory duct system, circulatory and lymph 
systems, and a physical support system.  The udder is inguinally located below the body 
and is formed by one or two pairs of mammary glands ending in teats.  The gland is 
supported internally by extensive connective tissue and ligaments, notably the median 
suspensory ligament, which aids in suspending the udder below the abdomen while 
keeping it close to the body wall.  Each teat is the drainage canal for one cistern.  The 
gland cistern collects secreted milk that drains from many ducts.  The ductal system is 
highly branched and leads from millions of lobuloalveoli.  Lobuloalveoli are clusters of 
alveoli, where each alveolus is made up of functionally differentiated mammary epithelial 
cells arranged in a single layer surrounding an open lumen into which components of 
milk are secreted.  The single layer of cells around the lumen is surrounded by 
myoepithelial cells that contract the alveolus to aid in the flow of milk through the ducts 
and ejection of milk into the cistern and out of the gland (Larson & Smith, 1974).  
Surrounding the alveoli is the mammary stroma, comprised of connective and adipose 
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tissue and a well developed vasculature (Larson & Smith, 1974; McManaman & Neville, 
2003). 
Mammogenesis 
The origination and development of the mammary gland begins during 
embryogenesis, during which time the mammary fat pad also develops (Sheffield, 1988; 
Daniel & Smith, 1999).  Interaction with the mesenchyme appears to be the most 
influential factor over the development of the mammary rudiment during embryogenesis 
and this interaction remains critical for proper development and function later in life 
(Daniel & Smith, 1999; Kleinberg, 1997).  Growth of the mammary gland prior to 
puberty is proportional to body growth (Knight, 2000).  The rudimentary ductal system 
present at birth will elongate, but with limited branching.  Development of secretory 
alveoli does not occur until the onset of pregnancy (Knight, 2000).  Other mammary 
gland tissues, such as connective, circulatory and lymph tissues, are developed during 
pre-pubertal growth (Takeishi et al., 1980). 
At the onset of puberty, the combined effects of pituitary and ovarian hormones 
stimulate further development of the mammary gland.  The synergistic effects of estrogen 
and GH serve to lengthen and branch the rudimentary ductal system (Kleinberg, 1997).  
Estrogen receptors begin to appear in high concentrations in the mammary gland during 
puberty, leading to ductal development within the gland in response to estrogen 
(Mallepell et al., 2006; Robinson et al., 1995).  Prolactin, secreted from the anterior 
pituitary in response to rising levels of estrogen, acts through its receptor on mammary 
cells to stimulate some post-pubertal development of alveoli and limited ductal 
elongation (Ceriani, 1974).  It has been suggested that prolactin stimulates paracrine 
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release of insulin-like growth factor II (IGF-II) within the mammary gland, which 
stimulates development of alveoli (Brisken et al., 2002). GH also promotes mammary 
epithelial proliferation, but to a much lesser extent than seen during gestation (Carstens et 
al., 1997; Sejrsen et al., 1986).  Stromal-epithelial interactions during puberty are 
especially critical, as the effects of GH are exerted through GH receptors (GHR) on 
stromal cells that produce local IGF-I that acts directly on mammary epithelial cells 
(MEC).  This paracrine action is essential for normal mammary development (Kleinberg 
& Ruan, 2008; Ruan & Kleinberg, 1999; Akers et al., 2000).  The presence of GH is 
critical for the proper development of the mammary gland.  In studies where 
hypophysectomized, ovariectomized, and adrenalectomized mice were given exogenous 
injections of hormones, no mammary development occurred at puberty in the absence of 
GH (Kleinberg, 1997).  In addition to GH, estrogens are critical for normal mammary 
development during puberty, particularly for hormone-dependent ductal elongation and 
side branching (Brisken & O'Malley, 2010).  For example, the mammary gland failed to 
develop in wild type mice with a cleared fat pad implanted with estrogen receptor 
negative epithelial cells (Mallepell et al., 2006).  Pubertal development of the mammary 
gland continues with each successive estrous cycle, until ducts reach the edges of the 
mammary fat pad, which marks the end of major pubertal development (Richert et al., 
2000).   
The onset of pregnancy elicits the next stage of development in the mammary 
gland.  Pregnancy induces major changes in the mammary gland to support terminal 
differentiation of alveolar structures in preparation for lactation.  The ductal system 
undergoes significant side-branching, alveolar development occurs, and MEC begin to 
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differentiate into functional secretory cells (Hovey et al., 2002; McManaman & Neville, 
2003).  Proliferation of MEC and development of alveoli are critical for milk production 
(Knight, 2000). Progesterone and prolactin play major roles in the proliferation of MEC 
and development of alveoli.  Under the influence of progesterone, branching of the ductal 
system becomes extensive and there is considerable development of lobulo-alveolar 
structures (Larson & Smith, 1974).  Sensitized by the effects of progesterone, the 
mammary gland responds to prolactin through the extensive development of 
lobuloalveolar structures (Hovey et al., 2003).  Additionally, the development of the 
mammary gland during pregnancy is modulated by the number of previous pregnancies.  
The mammary gland of multiparous animals responds more rapidly and robustly to 
progesterone and estrogen through increased proliferation and lobuloalveolar 
development (Ceriani, 1974).   
Lactation 
The sum of the changes acquired during pregnancy results in full functional 
differentiation of the MEC in preparation for synthesis and secretion of milk.  The 
secretory capacity gained by MEC during pregnancy is fully functional at the time of 
parturition.  There is an increase in Golgi, mitochondria, and endoplasmic reticulum in 
differentiated MEC, in addition to more secretory vesicles (McManaman & Neville, 
2003; Larson & Smith, 1974). Increasing levels of prolactin and decreasing levels of 
progesterone, which allows for secretion and ejection of milk, induce the onset of 
lactation (Knight, 2000). Synergistic effects of prolactin and GH maintain the production 
of milk components.  Prolactin and GH, through activation of their receptors, activate 
signal transducer and activator of transcription (STAT) variants, and particularly STAT5.  
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One of the major roles of STAT5 is increasing the transcription of milk protein genes 
(Rosen et al., 1999).  Prolactin stimulates the production of milk proteins in the MEC. 
GH indirectly acts on MEC, through the production of IGF-I, to stimulate lipid synthesis 
by maintaining activation of lipoprotein lipase and acetyl-CoA carboxylase (Knight, 
2001; Flint & Knight, 1997; Braun & Severson, 1992).  Additionally, cortisol is released 
during milking and is required to maintain secretory activation of MEC (Gorewit et al., 
1992; Sejrsen et al., 2006).  Although hormones play an important role in maintaining 
lactation, one of the most important and fundamental signals is suckling and/or milk 
removal (Svennersten-Sjaunja & Olsson, 2005).  Tactile stimulation of the teat results in 
release of the hormone oxytocin from the pituitary, which is required for full milk 
ejection (Svennersten-Sjaunja & Olsson, 2005; Gorewit et al., 1992).  The absence of any 
of these signals leads to the cessation of lactation through involution of the mammary 
gland.   
Involution 
Involution of the mammary gland at the end of lactation is the result of a complex 
signaling process through which the gland sheds MEC and mammary tissue is remodeled 
to a pre-pregnancy like structure (Baxter et al., 2007).  Regression of the mammary gland 
following the lactation cycle is a result of extensive apoptosis of MEC (Marti et al., 
1994). The major signal for mammary involution is the cessation of suckling which in 
turn leads to other signals resulting in activation of apoptosis.  The accumulation of milk 
in the alveolar lumen may be a signal for involution itself, or may contribute to the 
accumulation of apoptotic signals in the gland (Li et al., 1997).  Additionally, falling 
levels of hormones required for lactation contribute to regression of the gland.  These 
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signals lead to the activation of apoptotic pathways within MEC and regression of the 
gland to pre-gestational quiescence (Baxter et al., 2007).   
The result of involution is a loss of active secretory cells; however the gland 
retains a population of MEC that have not terminally differentiated.  These cells are 
retained and protected from the process of involution.  This population of stem cells is 
capable of responding to hormonal stimuli at the onset of the next gestation and 
proliferate to generate new secretory cells and a “new” functional gland (Malinowski, 
2005). 
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The mammary alveolar epithelial cell 
The major developmental stages of the mammary gland revolve around the 
proliferation and differentiation of mammary epithelial cells (MEC).  The functional units 
of the mammary gland are MEC, which synthesize and secrete the components of milk.  
This specialized cell absorbs nutrients from the blood stream, synthesizes components of 
milk, and secretes them into the alveolar lumen.  The alveolar lumen is composed of 
MEC arranged in a single layer surrounding the lumen, into which milk components are 
secreted.  Nutrients are absorbed through the basolateral membrane of MEC and milk 
components are secreted through the apical membrane of MEC (Wilde et al., 1995).  
Attaining this polarization is critical to the cell’s ability to successfully secrete milk 
components.  Without it, functional lactation fails (Tateyama et al., 1988). 
 During lactation MEC synthesize and secrete proteins unique to milk— caseins, 
lactalbumins, and lactoglobulins.  Milk protein gene expression is controlled through the 
synergistic interactions of prolactin, insulin, and dexamethasone (Menzies et al., 2009; 
Svennersten-Sjaunja & Olsson, 2005).  These hormones, through a signal cascade 
activated by binding their respective receptors, activate transcription factors that promote 
the transcription of milk protein genes (Rosen et al., 1999).  Caseins, which are 
hydrophobic milk proteins, are secreted in a micelle that also assists in the transport of 
calcium, lactose, and phosphate into milk (Kumar et al., 1994; Shennan & Peaker, 2000).  
-lactalbumin is a protein synthesized in MEC in response to hormonal stimuli during 
lactation.  In addition to being secreted as a milk protein to provide nutrients to the 
neonate, -lactalbumin also complexes with galactosyltransferase within the cell to form 
lactose synthase (Kresge & Simoni, 2006). Lactose synthase catalyzes the synthesis of 
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lactose from galactose and glucose in the Golgi (Larson, 1969). Without -lactalbumin, 
lactose synthase is not functional (Kresge & Simoni, 2006).   In this way, the expression 
of -lactalbumin, in response to prolactin, is directly linked to successful production of 
lactose during lactation. The concentration of lactose, in turn, regulates the volume of 
milk produced by changing osmotic pressure in the alveolar lumen which draws water 
from the blood into the lumen to balance the pressure (Shennan and Peaker, 2000). 
 In addition to milk specific proteins, MEC also synthesize and secrete lipids, 
predominately triacylglycerol (Shennan & Peaker, 2000).  The synthesis of fatty acids is 
markedly different between mammalian species.  Non-ruminants are able to utilize 
glucose for the synthesis of fatty acids through its conversion to citrate, which in turn can 
be cleaved by citrate lyase resulting in the formation of acetyl CoA, which can be utilized 
for fatty acid synthesis (Larson & Smith, 1974).  In ruminants, the use of glucose is 
prevented due to the absence of citrate lyase.  Fatty acids in ruminant milk are either 
derived from the blood by MEC or are synthesized by MEC from acetate and -
hydroxybutyrate, both of which are in high concentration in the ruminant as a result of 
microbial fermentation in the rumen (Larson & Smith, 1974).  Lipids are synthesized at 
the endoplasmic reticulum and are secreted as globules, surrounded by a portion of the 
apical cell membrane (Ernens et al., 2007).  Lipid droplets formed in the cytoplasm of 
MEC protrude out against the plasma membrane, eventually becoming enveloped, and 
extruded from the cell resulting in a secreted milk fat globule surrounded by plasma 
membrane (Keenan, 2001).   
 Nutrients are absorbed by MEC through the basolateral membrane and used to 
synthesize the components of milk.  Glucose and ions, such as potassium and sodium, 
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cross the MEC basolateral membrane through facilitated diffusion (Zhao et al., 1999; 
Shennan & Peaker, 2000).  Trace elements, such as zinc and copper, are moved by active 
transporters (Mather & Keenan, 1998; Truchet & Ollivier-Bousquet, 2009; Lonnerdal, 
2007).  Nutrients absorbed from the blood will be incorporated into larger molecules in 
milk, such as proteins or triacylglycerol, and secreted into the alveolar lumen, or be 
transported directly to the alveolar lumen.  Components that characterize milk are 
caseins, milk fat (predominately triglycerides), and lactose (Akers, 1985).  These are 
synthesized by MEC and secreted into milk along with other nutrients, such as vitamins 
and minerals.  
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Growth hormone 
Impact of GH 
Milk is a complete nutritional source and widespread production and distribution 
provides a source of complete nutrition to an ever-growing population.  Efficiency of 
milk production will be a key issue in both production of food for humans and efficient 
use of available resources.  Improving the utilization of nutrients by production animals, 
in addition to genetic improvements, can make the production of milk more efficient 
(Capper et al., 2008).  Early experiments in dairy cattle using crude pituitary extracts 
showed the presence of a factor which was a potent enhancer of milk yield (Cotes et al., 
1949).  Further purification identified it as growth hormone (GH).  Injections of 
exogenous GH or recombinant bovine somatotropin (rbST) improve feed conversion 
efficiency and increase milk yield in dairy cows.  Recently, recombinant technologies 
have allowed the widespread use of exogenous GH in the dairy industry.  In addition to 
providing a valuable food source, utilizing and maximizing exogenous GH technologies 
allows the current dairy cattle population to produce more milk while utilizing less feed.  
Efficiently using land and feed resources will continue to be a priority as the population 
expands and competition for land and resources increases (Capper et al., 2009; Capper et 
al., 2008). 
Despite improvements to production, the widespread use of rbST in dairy cattle has been 
controversial due to a perceived risk to the consumer as a result of ingestion of milk from 
cows treated with rbST.  There has been some concern that administration of rbST will 
increase the levels of IGF-I in milk, however any observed changes have been within the 
range of IGF-I normally present in milk (Dahl et al., 1991; Collier et al., 1999). 
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Growth hormone structure and secretion 
 GH, also called somatotropin, is a peptide hormone consisting of 190 or 191 
amino acids.  Four variants of GH have been described: either a leucine or valine at 
position 127, and either a 190-amino acid variant with a phenylalanine at the N-terminus, 
or a 191-amino acid protein with an alanine at the N-terminus (Etherton & Bauman, 
1998; Bauman & Vernon, 1993).  The potency of variants has been studied and the 
variant with a valine at position 127 has been reported to be a more potent stimulator of 
galactopoiesis, while no difference between N-terminal variants was observed with 
respect to galactopoiesis (Eppard et al., 1992). 
 Growth hormone releasing hormone, secreted from the hypothalamus, stimulates 
the secretion of GH from the pituitary gland.  Somatostatin, also secreted from the 
hypothalamus, inhibits the release of GH (Tuggle & Trenkle, 1996).  GH is secreted from 
the anterior pituitary gland in a pulsatile fashion (Gluckman et al., 1987) and acts on 
target tissues to promote growth.  Secretion from the pituitary is the major source of GH, 
however several other tissues also synthesize GH, including brain, placental, mammary 
and pineal gland (Butler & Le Roith, 2001).   
The GH receptor 
 The GH receptor (GHR) is a member of the cytokine receptor super-family and 
transmits signals through its membrane spanning structure via several signal transduction 
pathways (Shafiei et al., 2006).  The GHR shares a similar homology with other 
receptors, such as the prolactin and interleukin receptors (Butler & Le Roith, 2001).  
Activation of the GHR results in the phosphorylation and activation of Janus kinase 2 
(JAK2) that results in the phosphorylation of STAT proteins (STAT1, 3, and 5), mitogen-
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activated protein kinase (MAPK), and phophatidylinositol-3 kinase (PI3K) (CarterSu et 
al., 1996; Barclay et al., 2010).  The JAK2 pathway is particularly important for 
expression of IGF-I and IGF-I binding protein transcripts.  Activated STAT5 is able to 
regulate gene expression by binding DNA and activating gene transcription.  The critical 
importance of STAT5 activation, by both GH and prolactin, is highlighted by the 
discovery that STAT5 deficient mice are unable to lactate (Liu et al., 1997). 
 The GHR is present on several tissue types including liver, muscle, bone, 
mammary, adipose, brain, and immune tissue (Kopchick & Andry, 2000).  Via these 
receptors, GH is able to alter metabolic processes which result in an increase body mass 
and length.  There have been conflicting reports on the expression of the GHR on the 
MEC.  Early studies claimed that while the GHR was expressed in the mammary gland, it 
was most likely on stromal cells and not MEC (Peel & Bauman, 1987; Glimm et al., 
1990).  More recent studies utilizing more sensitive technologies have reported the 
expression of GHR mRNA and GHR on the membrane of MEC (Sakamoto et al., 2005; 
Plath-Gabler et al., 2001).  These findings led to investigations into the possibility of GH 
acting directly on MEC, in addition to its effects through somatomedins. 
Effects of GH 
 GH influences the development, growth, and metabolism of cells and tissues.  
Both direct and indirect effects of GH have been described: the direct effects of GH 
include changes in gene expression influencing and metabolism and differentiation of 
tissues, such as bone and mammary (Bolander, 1989). Indirect effects of GH are 
mediated by somatomedins (Peel et al., 1981; Bauman & Vernon, 1993). The major 
somatomedin associated with GH is insulin-like growth factor-1 (IGF-I), which is 
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produced and secreted by the liver in response to GH.  GHR is present in high 
concentrations on hepatocytes and allows GH to stimulate the production and secretion of 
IGF-I by the liver (Etherton & Bauman, 1998; Gluckman et al., 1987).  IGF-I acts 
through its receptor, present on most tissue types to induce changes to cell metabolism, 
division, and survival (Le Roith et al., 2001).  High serum concentrations of IGF-I 
contribute to negative feedback and inhibit the release of GH (Kopchick & Andry, 2000; 
Berelowitz et al., 1981). 
 Early experiments with pituitary extracts showed that they could promote growth 
and increase milk yield (Cotes et al., 1949; Lee & Schaffer, 1934). Exogenous injections 
of GH have been shown to increase milk yield and improve lactation persistency in dairy 
cattle without altering the composition of milk (Hutton, 1957; Akers, 2006).  Advances in 
recombinant technologies made the commercial application of GH feasible to the dairy 
industry.  Recombinant bovine GH was approved in 1993 by the FDA and marketed as 
Posilac® by Monsanto (Capper et al., 2008).  The increase in milk yield by GH is 
accomplished through several mechanisms.  Firstly, nutrient partitioning shunts nutrients 
in favor of the mammary gland through alterations in nutrient usage by other tissues, by 
increasing lipolysis in adipose tissue and decreasing glucose oxidation in muscle 
(Bauman & Currie, 1980; Pocius & Herbein, 1986).  These actions result in more 
nutrients being available to the mammary gland for synthesis of milk components 
(McDowell et al., 1987).  Secondly, GH contributes to cell survival by inhibiting 
apoptotic pathways and activating pathways involved with cell survival (Flint & Knight, 
1997).  This effect is primarily directed by IGF-I produced by the liver. 
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The metabolic effects of GH are a result of a direct action on target tissues, 
notably adipose and liver, altering their utilization of nutrients.  GH increases lipolysis in 
adipose tissue to release nutrients for use by other tissues, such as bone, muscle and 
mammary tissue (Butler & Le Roith, 2001).  GH increases lipid synthesis in animals with 
a positive energy balance, particularly growing animals, and increases lipolysis in 
animals with a negative energy balance, for example a lactating dairy cow.  This allows 
animals to grow and animals with high energy demands to better utilize available 
nutrients—such as in growing pigs and lactating dairy cows (Bauman & Currie, 1980). 
GH also increases protein accumulation, but this effect is largely mediated by increased 
concentrations of IGF-I (Etherton & Bauman, 1998).    Additionally, GH can stimulate 
glucose uptake by tissues in an insulin-dependent manner and this may be mediated by 
recruitment of the insulin receptor substrate by the GHR (Butler & Le Roith, 2001). 
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Insulin-like growth factors  
 There is clear evidence of a close relationship between GH and insulin-like 
growth factors (IGF).  The IGF family includes two growth factors, IGF-I and IGF-II, 
which share high amino acid homology.  Insulin-like growth factors (IGF) also share high 
homology with insulin (~50%); however IGF retain the C peptide that is cleaved from 
pro-insulin to make the functional form of insulin.  IGF-I and IGF-II both stimulate 
growth, however IGF-II is more involved in fetal growth, while IGF-I is involved in post-
natal growth (Bolander, 1989; Le Roith et al., 2001).  IGF-I and -II also promote 
mammary development, facilitating ductal elongation and branching, and alveolar 
development (Rowzee et al., 2009). In particular, IGF-I increases protein synthesis, 
cellular proliferation, and cell survival (Berry et al., 2001).   
 IGF are capable of binding three receptors with varying affinities:  the IGF-I 
receptor (IGFR-1), the IGF-II receptor (IGFR-2), and the insulin receptor (IR).  IGF 
receptors are present on a wide variety of tissues as is evident by the wide spread effects 
of IGF-I on multiple body systems.  IGFR-1 is the primary receptor for signaling the 
actions of IGF-I, but some functions may be mediated through IGFR-2.  Additionally, the 
IR binds IGF with 100-fold lower affinity than insulin (Stewart & Rotwein, 1996; Leroith 
et al., 1995).  The IR and the IGFR-1 share 70% homology (Baserga et al., 2003).  Both 
of these receptors are members of the tyrosine kinase receptor family and recruit the IR 
substrate and activate downstream signaling pathways such as PI3K and MAPK 
(Bolander, 1989). At high concentrations, IGF-I can bind the IR and can induce the 
uptake of glucose by tissues (McGuire et al., 1992). 
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 Synergistic hormonal interactions are critical to the development and function of 
the mammary gland (Topper & Freeman, 1980). The secretion of IGF-I, the major 
somatomedin associated with many of the effects of GH, is induced by GH (Berry et al., 
2001).  IGF-I is primarily secreted by the liver.  Metabolic effects of IGF-I include 
increased protein synthesis and decreased proteolysis, in addition to increased 
proliferation through stimulation of cell cycle progression (Sejrsen et al., 2006; Le Roith 
et al., 2001).  Additionally, IGF-I promotes cell survival through activation of Akt (Kulik 
et al., 1997). 
 Although the liver is the primary source of IGF-I production, other tissues such as 
mammary stroma can secrete IGF-I, which can act in a paracrine manner on MEC.  MEC 
have not been shown to secrete IGF-I (Baumrucker & Erondu, 2000).  When considered 
with MEC expression of the GHR, this further supports investigation into a separate, 
direct role of GH on MEC. 
IGF binding proteins 
 The majority of IGF-I and IGF-II are bound to binding proteins in serum (Cohick 
& Clemmons, 1993).  The involvement of IGF binding proteins (IGFBP) in the GH/IGF 
axis affects the ability of IGF to interact with their receptors.  There are at least six 
different IGF binding proteins whose secretion pattern and function differ (Knight, 2000).  
IGFBP aid in transport of IGF, prolong the half-life of IGF in circulation, and localize 
IGF to particular tissues through interactions with cell surface proteins and extracellular 
matrix proteins (Cohick, 1998; Cohick & Clemmons, 1993; Yamada & Lee, 2009).  The 
binding affinity of IGF for each binding protein differs between isoforms, tissues, and 
their interaction with other molecules (Rowzee et al., 2009).   
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 IGFBP-3 and IGFBP-5 both have major functions with respect to the mammary 
gland.  In dairy cattle, the predominant IGFBP in serum is IGFBP-3 which binds the 
majority of IGF-I in circulation (Baumrucker & Erondu, 2000; Plath-Gabler et al., 2001).  
IGFBP-3 is synthesized and secreted by mammary epithelial cells both in vivo and in 
vitro (Berry et al., 2001; Gibson et al., 1999; Cohick & Turner, 1998).  IGFBP-3 
concentrations have been shown to be higher during mammogenesis and involution than 
during lactation (Plath-Gabler et al., 2001; Baumrucker & Erondu, 2000).  It has been 
shown that IGFBP-5 is in high concentrations in the mammary gland during involution 
and appears to be involved in mediating the process of involution (Flint et al., 2003; 
Sakamoto et al., 2007). 
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Mammary functional models 
 The mammary gland provides an excellent model in which to study development, 
differentiation, and lactation; however, due to the numerous interconnected systems in a 
whole animal, a more independent model may be useful in deducing the role and 
functions of specific stimuli.  Apart from the whole-animal, there are several models that 
are useful in understanding the function of the mammary gland, each of which seek to 
best mimic the in vivo conditions of the mammary gland while eliminating confounding 
systemic factors.  Many studies report mammary tissue and cells in vitro are capable of 
responding to structural, nutritional, and hormonal stimuli (Keys et al., 1997; Campbell et 
al., 1991; Mills & Topper, 1970; Riley et al., 2008; Mallepell et al., 2006; Gibson et al., 
1999).  However, each of these models has limitations and varying culture requirements 
to achieve function in vitro.   
 One of the most fundamental requirements for normal function of MEC is 
polarization, which in some models must be achieved by a three-dimensional culture 
system.  Failure to determine cellular orientation, and consequently polarization, results 
in reduced expression of indicators of differentiation and lactation in MEC in vitro 
(Tateyama et al., 1988; Kawano et al., 1988).  For some in vitro MEC models, a collagen 
gel matrix is needed to provide support for proper polarization and expression of genes 
associated with the differentiated phenotype (Riley et al., 2010; Richards et al., 1983).  
Matrices can also be made from various materials designed to mimic the extra cellular 
matrix and thereby assist the orientation and polarization of cells in vivo (Grant et al., 
1985).  These matrices help to replicate the 3D structure and orientation of mammary 
tissue. 
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Explants 
 Explants are small pieces of excised mammary tissue and are composed of the 
many cells types present in the mammary gland including connective, adipose, vascular, 
and MEC.  Structural orientation is a key component of MEC differentiation and 
lactogenesis.  By culturing excised tissue, the physical orientation of the cells is 
maintained.  (Ebner et al., 1961).  Explants, however, can only be cultured for a relatively 
short time (up to 5 days) in vitro which makes long term studies difficult (Ip & Darcy, 
1996).  Additionally, it can be a costly and invasive procedure to continually excise 
mammary tissue; new tissue samples need to be obtained for every experiment because 
explants do not undergo proliferation in vitro and, unlike isolated primary cells, will not 
survive cryopreservation.  Due to the invasiveness of excising mammary tissue, tissue is 
often collected after slaughter; however this does not allow repeated sampling from the 
same animals.  Despite these drawbacks, explants provide an excellent model of the 
mammary gland in vitro and have been used by many groups to study functional 
differentiation, lactation, and involution.  Explants respond to hormonal stimuli in a 
similar fashion as the mammary gland; they are capable of differentiating, synthesizing 
and secreting milk proteins, IGFBP and, when co-cultured with liver and adipose tissue, 
lipids (Campbell et al., 1991; Keys et al., 1997; Keys et al., 1992).  However, they are 
not a homogeneous population of cells and investigating the response of a single cell type 
within the tissue can be confounded by stromal interactions between various cell types 
present. 
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Primary cells 
 Primary cells are isolated from mammary tissue and, depending on the method of 
isolation, can be a relatively homogenous population of MEC, free of other cell types 
found in the mammary gland.  The isolation of this singular cell type allows for 
investigation into the direct effects of signaling molecules, such as GH, upon the MEC 
without confounding influences from the surrounding tissue, which is especially 
important given the prevalence of paracrine signaling in the mammary gland.  However, 
isolated MEC have been dissociated from their connective tissue, and therefore the use of 
extra-cellular matrix scaffolds is common in single cell culture systems.  Despite these 
extra-cellular changes, primary cells provide an excellent model to study the proliferation 
and differentiation of MEC.  Using primary cell models, the importance of insulin, 
progesterone and epidermal growth factor in MEC proliferation has been shown (Ip & 
Darcy, 1996).  Additionally, the importance of prolactin, hydrocortisone, and insulin to 
the expression of milk proteins, especially casein, has been shown (Suard et al., 1983; 
Wheeler et al., 1995).  Studies using primary cells show their capability to synthesize and 
secrete lactose and lipids (Rohlfs et al., 1993; Taketani & Oka, 1981).   
 Mammary tissue is not the only source of primary MEC; primary MEC can also 
be isolated from milk.  Several groups have isolated MEC from raw milk from humans, 
cows, and goats (Gaffney, 1982; Boutinaud et al., 2002; Boutinaud et al., 2008; 
Buehring, 1990; Ceriani et al., 1979).  MEC are sloughed from the alveolus into milk and 
can be collected from samples of raw milk (Boutinaud & Jammes, 2002).  Several factors 
affect the concentration and viability of MEC in milk, such as stage of lactation, parity, 
infection, and milking frequency (Boutinaud & Jammes, 2002). The suitability of milk-
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derived MEC to represent the responses and functions of MEC has been evaluated by 
comparing the gene expression of mammary tissue to the gene expression of MEC 
derived from milk through RT-PCR (Boutinaud et al., 2008; Boutinaud et al., 2002).  
MEC derived from milk and mammary tissue have a significant correlation between the 
quantity and types of genes expressed (Boutinaud et al., 2002). 
Continuous cell lines  
 Cell lines are immortalized cells capable of continuous division in vitro.  They 
originate from cells isolated from tissue and through transfection or spontaneous 
mutation acquired the ability for indefinite proliferation.  Cell lines provide a virtually 
infinite source of cells, however their infinite proliferative ability calls into question their 
accurate representation of normal biological systems.  There are many mammary 
epithelial cell lines in use for multiple species.  In particular, the MAC-T cell line was 
derived from normal Holstein bovine mammary tissue by Huynh et al. (1991) and 
transfected with the simian virus 40 large-T antigen.  This transfection inhibits p53, a 
protein that regulates the cell cycle, allowing the cells to remain proliferative rather than 
reach senescence.  MAC-T cells are capable of synthesizing milk proteins and lipids.  In 
addition to the bovine derived MAC-T cell line, cell lines exist in other species including 
mice (COMMA-D, HC11) and humans (MCF-10A) (Ball et al., 1988; Soule et al., 1973; 
Danielson et al., 1984).  Cell lines have also been developed from tumor cells in several 
species, such as mice (4T1), human (MCF-7), and rats (Rama 25) (Dulbecco et al., 1979; 
Aslakson & Miller, 1992).  There are limitations to using transformed cell lines, however.  
These limitations stem from the inherent dysregulation of the cell cycle required to 
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achieve infinite proliferation and the possibilities of spontaneous mutations that may alter 
the ability of the cell line to respond in a similar fashion to its tissue of origin. 
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Project Rationale 
Utilizing two mammary cell models, this project aims to evaluate the response of 
primary bovine mammary cells to GH with an underlying comparison of the response 
between two dairy breeds.  This investigation is based on the clear influence of GH on 
milk yield in several dairy breeds and previous observations in mammary cell lines that 
support a direct action of GH on MEC.  The use of primary cells is critical for 
investigating the direct role of GH independent of IGF-I in normal cells.  Isolated 
primary cells provide a model where the response of MEC can be evaluated, independent 
of other stromal interactions. While investigations utilizing cell lines are certainly 
valuable, validating their responses in models that more closely resemble normal cells is 
an important step in elucidating the active mechanisms at work.   
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CHAPTER 2 
THE EFFECTS OF GROWTH HORMONE ON PRIMARY BOVINE 
MAMMARY CELL MODELS 
Introduction 
Early experiments in dairy cattle using crude pituitary extracts showed the 
presence of a factor which was a potent enhancer of milk yield (Cotes et al., 1949).  
Further purification identified it as growth hormone (GH) and its administration could 
increase milk yield (Hutton, 1957). With the utilization of recombinant technologies, 
commercial administration of exogenous GH became feasible.  Lactating animals 
respond to administration of exogenous GH by increasing milk production without 
altering composition (Hutton, 1957).  Previous studies have reported that high-producing 
animals differ from low-producing animals in their response to exogenous GH and 
suggest that this difference is due to the animal reaching maximum potential of milk 
production (Nytes et al., 1990; Gibson et al., 1992) or differences in the potency of GH 
variants (Etherton & Bauman, 1998).   
GH stimulates growth throughout the body through activation of the GH receptor 
(GHR).  The GHR activates several signal transduction pathways, such as Janus kinase 2 
(JAK2) and signal transducers and activators of transcription (STAT5).  The activation of 
these pathways promotes changes in cellular metabolism, differentiation, and 
transcription of GH-activated genes (Piwien-Pilipuk et al., 2002).  In particular, GH 
stimulates the production and secretion of insulin-like growth factor-1 (IGF-I) by the 
liver (Wilde et al., 1995). The direct action of IGF-I on target tissues affects cell 
metabolism, proliferation, and survival (Etherton & Bauman, 1998; Campbell et al., 
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1991).  In the mammary gland, IGF-I improves cell survival and increases protein 
synthesis in the mammary epithelial cell (MEC) (McGuire et al., 1992).  However, the 
actions of IGF-I are mediated by insulin-like growth factor binding proteins (IGFBP). 
There are several isoforms of IGFBP that have been described (IGFBP-1to -6) (Knight, 
2000).  IGFBP serve many functions and expression levels differ between isoforms and 
stage of the gland: development, lactation, or involution (Baumrucker & Erondu, 2000; 
Marshman & Streuli, 2002).  The major function of IGFBP is to bind IGF.  Through 
interactions with extracellular matrix proteins, cellular membrane proteins, and proteases, 
IGFBP regulate the localization and availability of IGF to its receptor (Marshman & 
Streuli, 2002; Le Roith et al., 2001). 
It is well established that GH increases the production of IGF-I by the liver and 
that IGF-I can act on many cell types, including MEC, resulting in increased milk 
production.  But, despite the well defined indirect action of GH on the mammary gland, 
the discovery of the GHR on the mammary epithelium led to the investigation of a direct 
action of GH on MEC (Plath-Gabler et al., 2001; Sakamoto et al., 2005; Hauser et al., 
1990).  A bovine derived mammary epithelial cell line, MAC-T, was shown to express 
the GHR (Zhou et al., 2008).  When the GHR and STAT5 were over-expressed, MAC-T 
cells responded to treatment with GH by increasing mRNA levels of major milk proteins 
(Zhou et al., 2008).  Additionally, it was observed that native MAC-T responded to 
treatment with GH resulting in an increase in mRNA levels of major milk proteins and 
altered lipid distribution (Johnson et al., 2010).  Previous research has also shown the 
proteome of native MAC-T cells is altered in response to treatment with GH.  GH 
induced changes in metabolic, cytoskeletal, and other proteins in differentiated MAC-T 
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cells (Johnson, 2010).  These observations indicate the possibility of a direct action of 
GH on MEC.    
Although MAC-T cells were originally derived from normal bovine mammary 
tissue, they were immortalized with the simian virus 40 large T antigen (SV40), which 
inhibits the ability of p53 and retinoblastoma protein to regulate cell division (Huynh et 
al., 1991).  Due to these known changes in cell cycle regulation, and the potential for 
changes to other regulatory mechanisms to have also been affected by SV40, the use of 
models which may more closely resemble conditions in vivo may better represent the 
response of MEC to GH.  
 Mammary explants from several species have been widely used to study the 
mammary gland (Keys et al., 1992; Sheehy et al., 2004; Brennan et al., 2008).  Explants 
retain the structure and orientation of the tissue in culture and preserve interactions 
between the stroma and epithelium (Sheehy et al., 2004; Keys et al., 1997).  However, 
mammary explants retain the surrounding stromal tissue in the gland and are not a 
homogenous cell population.  Due to the multiple cell types present, explants may not 
accurately represent the response of the MEC, but rather the complex intercellular 
interactions of the gland as a whole. 
To further segregate the direct effect of GH on MEC, primary MEC can be 
isolated and used to evaluate their response.  Primary cells have previously been used to 
study the metabolic functions and gene expression of the mammary gland (Suard et al., 
1983; Matitashvili & Bauman, 1999; Wheeler et al., 1995).  However, primary MEC are 
difficult and costly to obtain due to the invasive nature of sampling tissue from a lactating 
gland.  In addition, proliferation rates are limited and cultures often require complex 
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substrata (Ip & Darcy, 1996).  Limited proliferation of MEC impedes achieving adequate 
cell numbers for analysis and substrata can interfere with downstream protein analyses.  
Primary MEC are also shed into milk and can be isolated from a raw milk sample, and it 
has previously been shown that MEC in milk are viable (Taylor-Papadimitriou et al., 
1977; Stoker & Perryman, 1984; Ceriani et al., 1979; Buehring, 1990).  Transcript levels 
from mammary tissue and MEC from milk have previously been compared and found to 
be highly correlated (Boutinaud et al., 2002; Murrieta et al., 2006).  They may provide a 
MEC model that is non-invasive and easy to collect.   
Here, we compare the response of several MEC models to GH: explants, primary 
cells from tissue, and primary cells from milk.  To assess the potential of in vitro models 
to reflect differences between breed, models originating from two major dairy breeds, 
Holstein and Jersey, were studied. 
29 
Methods 
 All procedures involving animals were reviewed and approved by California 
Polytechnic State University, San Luis Obispo’s Institutional Animal Care and Use 
Committee.  Neomycin, enzymes in the collagenase cocktail, and metal mesh filters were 
obtained from Fisher Scientific (Pittsburg, PA).  Fetal bovine serum (FBS) was obtained 
from Innovative Research (Novi, MI).All other materials were obtained from Sigma 
Aldrich (St. Louis, MO) unless otherwise noted.  
Primary Cell Isolation 
Primary mammary cell isolation procedures were modified from earlier published 
reports (Ebner et al., 1961; Matitashvili & Bauman, 1999; Richards et al., 1983).  
Mammary tissue (200-300 g) was collected from multiparous (2nd lactation), lactating 
dairy cows (Jersey: 190 d in milk (DIM); Holstein: 125 DIM) immediately post mortem 
and placed in sterile saline with 1% penicillin-streptomycin-neomycin and 1% 
amphotericin B solution.  Excised tissue was washed in Dulbecco’s Modified Eagle 
Medium: Nutrient Mixture F-12 (DME:F12) with 1.25% penicillin-streptomycin-
neomycin and 1.25% amphotericin B and minced into 3-5 mm
3
 pieces.  Tissue was 
digested with a collagenase cocktail (DME:F12, 1% penicillin-streptomycin-neomycin, 
1% amphotericin B, 1 mg/mL collagenase, 0.5 mg/mL hyaluronidase, 1 U/mL elastase, 
20 g/mL DNAse) for 2.5 h at 30°C.  The cell suspension was filtered through three 
sterile metal mesh filters of decreasing size (380 m, 230 m, 100 m); and tissue 
remaining on the filters was digested for an additional 2.5 h in fresh collagenase cocktail 
and filtered again. Following filtration, the cell suspension was washed by centrifugation 
(5 min, 1000g, 15°C) in Wash 1 (DME:F12 with 1% penicillin-streptomycin-neomycin, 
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1% amphotericin B, 5% FBS and 40 g/mL DNAse) until the supernatant was clear.  The 
pellet was resuspended in Wash 1 and loaded atop a 3-step Ficoll-BSA gradient (5%, 
10%, 15% BSA in Ficoll) and centrifuged (1 h, 1420g, 15°C) with no brake.  The 
epithelial cell band (Figure 1) was removed and washed 3 times by centrifugation (5 min, 
1000g, 15°C) in Wash 2 (DME:F12 with 1% penicillin-streptomycin-neomycin, 1% 
amphotericin B, 5% FBS).  Each wash step consisted of resuspending the pellet in 50 mL 
of Wash 2, centrifuging, and discarding the supernatant.  Purified epithelial cells were 
cryopreserved in 1mL aliquots (~6x10
6
 cells/vial) of freezing media with DMSO.  Cells 
were initially stored for 24 h at -80°C and then transferred to liquid nitrogen for long 
term storage.     
MEC Isolation from Milk 
To isolate mammary epithelial cells from milk, raw milk (800mL) was collected 
from four lactating dairy cows (125±15 DIM) 2 h after parlor milking and placed on ice.  
0.5mM EDTA was added and raw milk was centrifuged at 500g for 20 minutes.  The 
cream layer and supernatant were discarded.  The remaining pellets were pooled by re-
suspension in 1X PBS with 1% penicillin-streptomycin and 0.5mM EDTA and then 
passed through a 100uM cell strainer.  The pooled cell suspension was washed 3 times in 
1X PBS-penicillin-streptomycin by centrifugation (10 min, 500g, 4°C); after each wash, 
the supernatant was discarded and the pellet resuspended.  Finally, the pellet was 
resuspended in 10 mL DMEM with 1% penicillin-streptomycin and layered on top of a 3-
step Ficoll-BSA gradient (5%, 10%, 15% BSA in Ficoll) and centrifuged (1 h, 1420g, 
15°C) with no brake.  The epithelial cell band (Figure 1) was removed and washed 3 
times in DMEM with 1% penicillin-streptomycin.  Each wash step consisted of 
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resuspending the pellet in 50mL of DMEM with 1% penicillin-streptomycin, centrifuging 
(5 min, 1000g, 15°C), and discarding the supernatant.  Purified epithelial cells were 
cultured immediately. 
Explant Culture 
Explants were obtained at the same time as tissue for primary cell 
isolation.  Tissue was rinsed in a solution containing 49% DME:F12, 49% Hanks’ 
buffered saline solution, 1% penicillin-streptomycin-neomycin and 1% amphotericin B 
and cut into 1 mm
3
 pieces.  10-15 pieces of tissue were transferred to Falcon tubes 
containing DMEM with 10% FBS, 1% penicillin-streptomycin, 5 g/mL porcine insulin, 
5 g/mL ovine prolactin, 1 g/mL dexamethasone with 0 ng/mL or 10 ng/mL GH and 
cultured for 12 h at 37°C with 5% CO2. 
Primary Cell Culture   
 Prior to seeding, plates were coated with 10 g of bovine collagen per cm2 of 
growth area (Santa Cruz Biotechnology, Paso Robles, CA) diluted in 0.01M HCl.  The 
collagen was allowed to incubate at room temperature for 1-2 h.  The plates were rinsed 
three times with 1X PBS prior to seeding.  Primary cells were then cultured on collagen-
coated 6-well plates in M199:NCTC 135 with 12% FBS, 1% penicillin-streptomycin, 1% 
amphotericin B, 5 g/mL porcine insulin, 1 g/mL progesterone, 1 g/mL 
dexamethasone, 5 g/mL bovine transferrin, 5 M ascorbic acid, 5 mM sodium acetate 
(INS/PROG) at 37°C with 5% CO2.  At 75-80% confluence, media was changed to 
M199:NCTC 135 with 12% fetal bovine serum (FBS), 1% penicillin-streptomycin, 1% 
amphotericin B, 5 g/mL porcine insulin, 5 g/mL ovine prolactin, 1 g/mL 
dexamethasone, 5 g/mL bovine transferrin, 5 M ascorbic acid, 5 mM sodium acetate 
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with 0 ng/mL (DIP) or 10 ng/mL GH (DIP+GH).  Primary cells were cultured for the 
duration indicated in Figures 5, 6, 8 and 9. 
Culture of MEC from Milk 
Milk epithelial cells were cultured on collagen-coated wells (10ug/cm
2
), prepared 
as described above, in M199:NCTC 135 with 12% FBS, 1% penicillin-streptomycin, 1% 
amphotericin B, 5 g/mL porcine insulin, 1 g/mL progesterone, 1 g/mL 
dexamethasone, 5 g/mL bovine transferrin, 5 M ascorbic acid, 5 mM sodium acetate 
(INS/PROG) at 37°C with 5% CO2.  At 75-80% confluence, media was changed to 
M199:NCTC 135 with 12% FBS, 1% penicillin-streptomycin, 1% amphotericin B, 5 
g/mL porcine insulin, 5 g/mL ovine prolactin, 1 g/mL dexamethasone, 5 g/mL 
bovine transferrin, 5 M ascorbic acid, 5 mM sodium acetate with 0 ng/mL (DIP) or 10 
ng/mL GH (DIP+GH).  Cells were cultured for the durations listed in Figures 7, 10, and 
11. 
Immunocytochemistry 
Isolated primary cells were stained with an anti-type II cytokeratin antibody to 
confirm epithelial origin.  Type II cytokeratins are intermediate filaments of the 
intracytoplasmic skeleton (Alberts et al., 2008).  All steps were performed at room 
temperature.  At 60% confluence, cells were fixed for 30 minutes with 4% formalin in 
PBS with 0.1% Triton X100.  Cells were blocked for 20 minutes with 10% FBS in PBS 
and then incubated with a mouse anti-cytokeratin (type II) antibody (sc-57004, Santa 
Cruz Biotechnology, Santa Cruz, CA) for 1 hour on a plate rotator.  A fluorescein 
isothiocyanate (FITC)-conjugated goat anti-mouse IgG secondary antibody was used for 
visualization (sc-2010, Santa Cruz Biotechnology).  Nuclei were stained with propidium 
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iodide (PI) (Santa Cruz Biotechnology).  Cells were visualized using an upright 
microscope with appropriate filters.  FITC and PI images were then overlaid using Adobe 
Photoshop CS3. 
Flow Cytometry 
Cryopreserved primary cells were thawed and immediately fixed for 15 minutes 
at room temperature using 0.01% formaldehyde in PBS.  Permeabilizing solution (PBS 
with 0.5% Tween 20) was added and cells were incubated at room temperature for 15 
minutes.  An additional volume of permeabilizing solution was added and cells were 
pelleted by centrifugation at 280g for 5 minutes.  Cells were resuspended in dilution 
buffer (PBS with 10% FBS and 1% sodium azide) and diluted to 500,000 cells/mL.  Cells 
were incubated overnight at 4°C with 3% BSA and primary antibody, mouse anti-
cytokeratin (type II) antibody (sc-57004, Santa Cruz Biotechnology).  The cells were then 
pelleted and resuspended in dilution buffer, followed by incubation with 3% BSA and the 
secondary FITC-conjugated goat anti-mouse IgG secondary antibody (sc-2010, Santa 
Cruz Biotechnology) overnight at 4°C.  Cells were then pelleted and washed twice with 
ice cold dilution buffer.  Fluorescently labeled cells were quantified using a Guava 
EasyCyte flow cytometer (Millipore, Billerica, MA). 
RNA Extraction and cDNA synthesis 
Total RNA was extracted from all tissue and cell cultures using the RNeasy kit 
according to the manufacturer’s instructions (Qiagen, Valencia, CA).  Up to 1g of total 
RNA was reverse transcribed using the IScript Kit (Bio-Rad, Hercules, CA) according 
the manufacturer’s instructions. 
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Quantitative PCR 
The relative abundance of αS1-casein, α-lactalbumin, GH receptor, IGF-I, and 
IGFBP-3 mRNA transcripts was determined with quantitative PCR using Fast SYBR 
Green Master mix (Applied Biosystems, Foster City, CA).  For primer sequence and 
design, see Table A.  Quantitative PCR was analyzed using the 2
-ΔΔCT method (Livak & 
Schmittgen, 2001) with mRNA transcripts of 18S RNA (18S), -actin (ACTB), TATA-
binding protein (TBP), or RNA polymerase I, polypeptide D (POLRD1) serving as 
internal controls. 
Statistical Analysis 
For explants and primary cells, tissue was collected from one Holstein cow (125 
DIM) and one Jersey cow (190 DIM).  For milk derived MEC, milk from four cows was 
pooled (125±15 DIM).  Each experiment was carried out in triplicate.  Normalized data 
were analyzed using the general linear model in SAS 9.0 (SAS Institute, Inc., Cary, NC).  
Differences were considered significant at P < 0.05.  Data are represented as the mean ± 
SEM. 
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Figure 1: MEC band at the interface of media and 5%BSA-Ficoll layers. 
MEC were isolated from either digested mammary tissue or raw milk using a 3-step 
BSA-Ficoll density gradient (5%, 10%, 15% layers).  Cell suspensions were layered on 
the top of the 5% BSA-Ficoll gradient layer and centrifuged.  Cell types separated 
according to density and a heavy band of epithelial cells is visible at the interface of the 
media layer and 5%BSA-Ficoll layer, as indicated by the green arrow.   
 Target Sense Primer (5’ – 3’) Antisense Primer (5’-3’) Source* 
LALBA AAAGACGACCAGAACCCTCA GCTTTATGGGCCAACCAGTA Zhou et al., 2008 
CSN1S1 AATCCATGCCCAACAGAAAG TCAGAGCCAATGGGATTAGG Zhou et al., 2008 
GHR CTAACTAGCAATGGCGGT GGGTGGATCTGGTTGTACTA Johnson et al., 2010 
IGF-I TCACATCCTCCTCGCATCTCTTCT AACTGGAGAGCATCCACCAACTCA BC126802.1 
IGFBP3 AAAGAGATGTTTGAAATGCCTAGTTTT TCAAACTCGGTTTCACTGACTACTG Voge et al, 2004 
18S GTAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG Zhou et al., 2008 
ACTB GCGTGGCTACAGCTTCACC TTGATGTCACGGACGATTTC Bionaz and Loor, 2007 
TBP TGAAACGACTTAGCAGCAGCAGCA TGCTCGGCTCTGTGGGTTATCTTT BC113308.1 
POLRD1 GCCCGCACGCTTCGAGGCAT GTCCCAGCCGCCTGGACCAT NM_001076144.1 
Table A: Primers based on bovine mRNA sequences used for quantitative PCR in this study. 
Primers used for quantitative PCR analysis of gene expression in mammary epithelial cells cultured with 0 or 10 ng/mL GH. * Primers 
were obtained based on sequences reported in the reference listed, or were designed and analyzed using Primerquest Software 
(Integrated DNA Technologies, Coralville, IA) and NetPrimer (Premier Biosoft International, Palo Alto, CA) based on the GenBank 
accession numbers listed. 
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Results 
 Isolated cells were confirmed to be epithelial using immunocytochemistry (Figure 
2) and flow cytometry.  Cultured cells were stained using a monoclonal cytokeratin type 
II antibody.  Cell populations in culture predominately stained positive for cytokeratin 
type II indicating their epithelial origin. Additionally, primary cell isolates were 
quantified as 53% and 58% positive for cytokeratin (Jersey and Holstein respectively) by 
flow cytometry (Figure 3, Table B)  
Explants 
 Mammary explants from a lactating Jersey cow showed an increase in -
lactalbumin mRNA abundance in response to GH (P < 0.05), however, no other targets 
measured were affected at 12 h by treatment with GH (Figure 4).     
Primary cells 
 Primary cells from both breeds responded to classical lactogenic media through 
continued expression of milk protein genes.  Primary cells isolated from Jersey mammary 
tissue showed few changes in response to GH.  GHR mRNA abundance was increased in 
response to GH when measured at 2 and 7 d (P < 0.05), but no difference was observed at 
4 d (Figure 5 and Figure 9).  The abundance of milk protein mRNA, -lactalbumin and 
s1-casein, did not change in response to GH.  However, a noteworthy trend occurred in 
IGFBP-3 mRNA expression.  The mRNA abundance of IGFBP-3 tended to increase 
between d 2 and d 4 of treatment, however, this difference was not significant.   
After 7 d, primary cells isolated from Holstein mammary tissue did not show a 
significant difference in the mRNA abundance of any target measured (Figure 6).  
However, a shorter treatment duration, 4 d, showed a decrease in IGFBP-3 mRNA 
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abundance in response to GH, as seen in Figure 8, but no other targets were affected.  
After 4 d of treatment with GH, IGFBP-3 mRNA abundance was significantly decreased 
in comparison to cells not treated with GH (P < 0.05) (Figure 8).  Although not 
significant, a similar trend was also observed at 2 d of treatment (P<0.1). 
MEC from Milk 
 MEC isolated from milk showed a limited response to GH.  In cells from Holstein 
milk, an increase in -lactalbumin mRNA abundance was observed in response to GH 
(P<0.05).  The increase in s1-casein mRNA, although not statistically significant, 
exhibited changes similar to what was previously observed in MAC-T cells.  Johnson et 
al. observed an increase in s1-casein mRNA in differentiated MAC-T cells, compared to 
undifferentiated, and between MAC-T differentiated with GH, compared to those 
differentiated without.  GHR mRNA abundance was significantly increased at 7 d in 
Holstein milk cells cultured in lactogenic media when compared to cells cultured in 
growth media (P<0.05) but was not affected by treatment with GH (Figure 7).  
Additionally, a decrease in IGFBP-3 mRNA abundance in response to GH was observed 
at day 4 (Figure 10).  This pattern was also observed in Holstein primary cells (Figure 8). 
MEC from Jersey milk showed no changes in mRNA abundance of any target measured 
in response to GH.  However, a similar trend in IGFBP-3 mRNA abundance was 
observed between Jersey primary cells and MEC from Jersey milk—IGFBP-3 mRNA 
abundance was increased at day 4 in response to GH (Figure 9and 11). 
 
39 
 
Figure 2: Isolated cells are of epithelial origin. 
Immunocytochemistry showed cultured cells to be predominately positive for cytokeratin 
expression, indicating their epitheliality.  Images are representative of 
immunocytochemistry performed on isolated MEC.  Panel A shows nuclei stained with 
propidium iodide; panel B shows cells positive for cytokeratin type II stained using 
FITC; panel C shows the two images over-layed using Adobe Photoshop. 
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Figure 3: Isolated cells are positive for epithelial marker proteins. 
Primary MEC were stained with a primary antibody against cytokeratin type II and a 
FITC-conjugated secondary antibody, then quantified using flow cytometry (A: Jersey, 
B: Holstein).  Gates were set relative to control samples (cells only incubated with 
secondary antibody).  Unstained cells are represented by black dots (control); cells 
stained with fluorescent antibody against cytokeratins (type II) are represented by red 
dots (stained).  Quantified results are displayed in Table B. 
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  Cell count  
Source Sample 
Lower left 
quadrant 
Upper left 
quadrant 
Total % positive 
Jersey 
control 4000 0 4000 0 
stained 1782 2218 4000 55.45 
Holstein 
control 3986 14 4000 0.35 
stained 1661 2339 4000 58.48 
Table B: Primary MEC flow cytometry values. 
Primary cells were stained with an antibody against cytokeratin type II and a FITC 
conjugated antibody.  Cells were quantified using flow cytometry.  Four individual 
samples were tested.  Counts were compiled into the represented values.     
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Figure 4: -lactalbumin mRNA abundance in Jersey mammary explants is 
increased after 12 h in response to GH. 
Mammary explants from a lactating Jersey cow show a limited response to GH, with only 
the mRNA abundance of -lactalbumin being affected by GH.  Explants taken from 
lactating mammary tissue from a Jersey cow were cultured for 12 h in DMEM with 10% 
FBS, 1% penicillin-streptomycin, 5 g/mL porcine insulin, 5 g/mL ovine prolactin, 1 
g/mL dexamethasone with 0 ng/mL GH (DIP) or 10 ng/mL GH (DIP+GH) and 
cultured for 12 hrs at 37°C with 5% CO2.  Total RNA was extracted and reverse 
transcribed.  Targets were analyzed using quantitative PCR.  Bars represent the 
mean±SEM.  An asterisk (*) denotes a significant difference (P<0.05). 
 
* 
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Figure 5: In primary MEC from a Jersey cow, GHR mRNA abundance is increased 
in response to GH after 7 d. 
Primary MEC from a Jersey cow show an increase in GHR mRNA abundance after 7d in 
response to treatment with GH.  Confluent primary MEC isolated from lactating Jersey 
mammary tissue were cultured for 7 d in M199:NCTC 135 with 12% FBS, 1% penicillin-
streptomycin, 1% amphotericin B, 5 g/mL porcine insulin, 5 g/mL ovine prolactin, 1 
g/mL dexamethasone, 5 g/mL bovine transferrin, 5 M ascorbic acid, 5 mM sodium 
acetate with 0 ng/mL (DIP) or 10 ng/mL GH (DIP+GH)at 37°C with 5% CO2.  Total 
RNA was extracted and reverse transcribed.  Targets were analyzed using quantitative 
PCR.  Bars represent the mean±SEM.  An asterisk (*) denotes a significant difference 
(P<0.05). 
 
  
* 
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Figure 6: Primary MEC from a Holstein do not respond to treatment with GH after 
7 d.   
No change in the mRNA abundance of targets in primary MEC from Holstein mammary 
tissue was observed after 7 d in response to GH.  Confluent primary MEC isolated from 
lactating Holstein mammary tissue were cultured for 7 d in M199:NCTC 135 with 12% 
FBS, 1% penicillin-streptomycin, 1% amphotericin B, 5 g/mL porcine insulin, 5 g/mL 
ovine prolactin, 1 g/mL dexamethasone, 5 g/mL bovine transferrin, 5 M ascorbic 
acid, 5 mM sodium acetate with 0 ng/mL (DIP) or 10 ng/mL GH (DIP+GH)at 37°C with 
5% CO2.  Total RNA was extracted and reverse transcribed.  Targets were analyzed using 
quantitative PCR.  Bars represent the mean±SEM. 
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Figure 7: In MEC from Holstein milk, -lactalbumin mRNA abundance is 
increased in response to treatment with GH after 7 d. 
Abundance of -lactalbumin mRNA in MEC from Holstein milk cultured with GH was 
increased after 7 d in culture.  Additionally, s1-casein mRNA abundance was greater in 
MEC differentiated with GH, than undifferentiated MEC.  GHR mRNA abundance was 
greater in differentiated MEC.  MEC isolated from milk were cultured in M199:NCTC 
135 with 12% FBS, 1% penicillin-streptomycin, 1% amphotericin B, 5 g/mL porcine 
insulin, 1 g/mL progesterone, 1 g/mL dexamethasone, 5 g/mL bovine transferrin, 5 
M ascorbic acid, 5 mM sodium acetate (INS/PROG) until confluent.  At 75-80% 
confluence, media was changed to M199:NCTC 135 with 12% FBS, 1% penicillin-
streptomycin, 1% amphotericin B, 5 g/mL porcine insulin, 5 g/mL ovine prolactin, 1 
g/mL dexamethasone, 5 g/mL bovine transferrin, 5 M ascorbic acid, 5 mM sodium 
acetate with 0 ng/mL (DIP) or 10 ng/mL GH (DIP+GH) and cultured for 7 d.  Total 
RNA was extracted and reverse transcribed.  Targets were analyzed using quantitative 
PCR.  Bars represent the mean±SEM.  A superscript denotes a significant difference 
(P<0.05). 
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Figure 8: Primary Holstein MEC have decreased IGFBP-3 mRNA abundance after 
4 d of treatment with GH.  
Primary MEC from a Holstein cow responded to GH with a decrease in mRNA 
abundance of IGFBP-3 after 4 d; a similar pattern is also seen after 2 d, although not 
statistically significant.  MEC isolated from Holstein mammary tissue were cultured in 
M199:NCTC 135 with 12% FBS, 1% penicillin-streptomycin, 1% amphotericin B, 5 
g/mL porcine insulin, 1 g/mL progesterone, 1 g/mL dexamethasone, 5 g/mL bovine 
transferrin, 5 M ascorbic acid, 5 mM sodium acetate (INS/PROG) until confluent.  At 
75-80% confluence, media was changed to M199:NCTC 135 with 12% FBS, 1% 
penicillin-streptomycin, 1% amphotericin B, 5 g/mL porcine insulin, 5 g/mL ovine 
prolactin, 1 g/mL dexamethasone, 5 g/mL bovine transferrin, 5 M ascorbic acid, 5 
mM sodium acetate with 0 ng/mL (DIP) or 10 ng/mL GH (DIP+GH) and cultured for 2 
and 4 d.  Total RNA was extracted and reverse transcribed.  Targets were analyzed using 
quantitative PCR.  Bars represent the mean±SEM.  A superscript denotes a significant 
difference (P<0.05) 
DAY 2 DAY 4 DAY 2 DAY 4 
DAY 2 DAY 4 
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Figure 9: Primary Jersey MEC have increased GHR mRNA abundance after 2 d in 
response to treatment with GH.  
GHR mRNA abundance was significantly greater in MEC after 2 d in response to 
treatment with GH.  No other targets were affected by GH.  MEC isolated from 
mammary tissue from a Jersey cow were cultured in M199:NCTC 135 with 12% FBS, 
1% penicillin-streptomycin, 1% amphotericin B, 5 g/mL porcine insulin, 1 g/mL 
progesterone, 1 g/mL dexamethasone, 5 g/mL bovine transferrin, 5 M ascorbic acid, 
5 mM sodium acetate (INS/PROG).  At 75-80% confluence, media was changed 
M199:NCTC 135 with 12% FBS, 1% penicillin-streptomycin, 1% amphotericin B, 5 
g/mL porcine insulin, 5 g/mL ovine prolactin, 1 g/mL dexamethasone, 5 g/mL 
bovine transferrin, 5 M ascorbic acid, 5 mM sodium acetate with 0 ng/mL (DIP) or 10 
ng/mL GH (DIP+GH) and cultured for 2 and 4 d.  Total RNA was extracted and reverse 
transcribed.  Targets were analyzed using quantitative PCR.  Bars represent the 
mean±SEM.  A superscript denotes a significant difference (P<0.05). 
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Figure 10: Holstein MEC from milk have decreased mRNA abundance of IGFBP-3 
after 4 d in response to treatment with GH.  
IGFBP-3 mRNA abundance is decreased in MEC from Holstein milk after 4 d in 
response to treatment with GH.  No other targets were affected by GH.  MEC isolated 
from Holstein milk were cultured in M199:NCTC 135 with 12% FBS, 1% penicillin-
streptomycin, 1% amphotericin B, 5g/mL porcine insulin, 1g/mL progesterone, 
1g/mL dexamethasone, 5 g/mL bovine transferrin, 5M ascorbic acid, 5mM sodium 
acetate (INS/PROG).  At 75-80% confluence, media was changed M199:NCTC 135 with 
12% FBS, 1% penicillin-streptomycin, 1% amphotericin B, 5g/mL porcine insulin, 
5g/mL ovine prolactin, 1g/mL dexamethasone, 5g/mL bovine transferrin, 5M 
ascorbic acid, 5mM sodium acetate with 0ng/mL (DIP) or 10ng/mL GH (DIP+GH) and 
cultured for 2 and 4 d.  Total RNA was extracted and reverse transcribed.  Targets were 
analyzed using quantitative PCR.  Bars represent the mean±SEM.  A superscript denotes 
a significant difference (P<0.05)  
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Figure 11: In MEC from Jersey milk, the mRNA abundance for any transcript 
evaluated was not affected by GH.  
Although mRNA transcript abundance was not affected by GH, s1-casein mRNA 
abundance was greater in MEC differentiated with GH than in undifferentiated MEC 
after 2 days.  MEC isolated from Jersey milk were cultured in M199:NCTC 135 with 
12% FBS, 1% penicillin-streptomycin, 1% amphotericin B, 5 g/mL porcine insulin, 1 
g/mL progesterone, 1 g/mL dexamethasone, 5 g/mL bovine transferrin, 5 M 
ascorbic acid, 5 mM sodium acetate (INS/PROG).  At 75-80% confluence, media was 
changed M199:NCTC 135 with 12% FBS, 1% penicillin-streptomycin, 1% amphotericin 
B, 5 g/mL porcine insulin, 5 g/mL ovine prolactin, 1 g/mL dexamethasone, 5 g/mL 
bovine transferrin, 5 M ascorbic acid, 5 mM sodium acetate with 0 ng/mL (DIP) or 10 
ng/mL GH (DIP+GH) and cultured for 2 and 4 d.  Total RNA was extracted and reverse 
transcribed.  Targets were analyzed using quantitative PCR.  Bars represent the 
mean±SEM.  A superscript denotes a significant difference (P<0.05). 
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Discussion 
Recently, two studies utilizing MAC-T cells have reported a direct response to 
GH (Johnson et al., 2010; Zhou et al., 2008).  One study utilizing transformed MAC-T 
cells which over-express the GHR and STAT5 reported a significant increase in the 
mRNA expression of -lactalbumin and s1-casein, and other milk proteins in response 
to GH (Zhou et al., 2008).  GHR mRNA was over-expressed in MAC-T cells because it 
appeared to be in very low abundance when quantified by a ribonuclease protection 
assay.  Additionally, Johnson et al. reported that native MAC-T cells cultured for 7 d in 
lactation media with 0 or 10ng/mL GH showed increased -lactalbumin and s1-casein 
mRNA in response to GH, in addition to increased abundance of the GHR mRNA 
(Johnson et al., 2010). Prior proteomic work in the MAC-T cell line has shown a direct 
effect of GH which induced changes in abundance of proteins involved in cytoskeletal 
arrangement, metabolism and lactogenesis, indicating that GH plays a role in stabilizing 
the cell and preparing it for lactation (Johnson, 2010). Although MAC-T cells provide a 
useful model of MEC, undergoing immortalization may have altered their ability to 
model normal MEC function.  Here, the direct effect of GH on MEC was investigated 
using three primary in vitro MEC models: explants, primary MEC isolated from whole 
mammary tissue, and primary MEC derived from milk.  Mammary explants and primary 
cells did not express the same response to GH as previously observed in MAC-T cells.  
While some primary mammary models showed an increased abundance of milk proteins 
in response to GH, no model reproduced the robust response to GH observed in MAC-T 
cells. 
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 As previously indicated, in vitro primary cell models provide an isolated cell 
model of MEC.  However, because there is some dispute as to whether MEC themselves 
express and secrete IGF-I, or if it is only produced by near-by stromal cells, and because 
the in vivo role of GH is coupled with IGF-I, the mRNA abundance of IGF-I was 
investigated to evaluate the influence, if any, IGF-I may play in in vitro mammary 
models.  IGF-I mRNA was found in all models studied.  This may be expected in 
explants because it is well documented that the mammary stroma synthesizes and secretes 
IGF-I (Kleinberg, 1997; Fleming et al., 2005).  However, in isolated populations of 
MEC, IGF-I mRNA was also detected.  It has been previously reported that the mammary 
epithelium does not express IGF-I mRNA (Campbell, 1988).  Zhou et al. reported the 
expression of IGF-I mRNA in transfected MAC-T; however, its abundance was not 
affected by treatment with GH (Zhou et al., 2008).  Here, IGF-I mRNA was detected in 
both mammary explants and primary cells, however IGF-I mRNA abundance was not 
affected by treatment with GH.  This indicates the observed changes in IGFBP-3 mRNA 
abundance are likely a result of a direct action of GH, and not due to the autocrine or 
paracrine effects of increased IGF-I being secreted in response to GH. 
  Expression of GHR mRNA was detected in mammary explants and primary cells 
from tissue and milk.  The presence of GHR mRNA supports the possibility of a direct 
role of GH on MEC; however, that role does not appear to be directly mediating an 
increase in milk components to the same magnitude observed in MAC-T.  Only explants 
and MEC from Holstein milk showed a significant increase in -lactalbumin in response 
to GH.  Based on these results, and proteomic changes previously observed in the MAC-
T cell line, the direct action of GH on the MEC may have influence over differentiation 
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and regulate binding proteins to alter the availability of IGF-I, rather than exerting a 
direct effect on milk synthesis and secretion. 
 A previous study evaluating the response of Holstein and Jersey cows to GH 
reported differences in their capacity to respond to GH (West et al., 1990).  West et al. 
reported that in Holsteins as the dose of GH increased, milk yield increased in a linear 
fashion in Holsteins; however, in Jerseys, as the dose of GH increased over the same 
range, milk yield only increased until the dosage of GH reached 15mg and then declined 
at higher doses.  A similar difference in breed response is observed in the current results.  
IGFBP-3 mRNA abundance is altered by GH and the effect differs between breeds.  
Primary and milk cells from Holsteins showed a decrease in IGFBP-3 mRNA abundance 
in response to GH after 4 d.  In both primary and milk MEC from Jersey cows, no change 
was observed in response to GH, however, IGFBP-3 abundance tended to increase from 
day 2 and day 4 regardless of GH treatment.  Changes in the abundance of IGFBP-3 may 
affect the actions of the GH-IGF axis, because IGFBP-3 is the major binding protein for 
IGF-I (Baumrucker and Erondu, 2000).  For example, mammary epithelial cells isolated 
from Holsteins may be able to better respond to GH because GH inhibits the production 
of IGFBP-3, allowing more IGF-I to remain unbound and able to interact with its 
receptor.  This proposed model is diagramed in Figure 12. 
The roles of IGFBP are not fully understood, however, it is well established that 
they bind IGF-I, can extend its half-life in serum, limit the availability of IGF-I, can aid 
in the localization of IGF-I to a particular tissue through interactions with extracellular 
matrix proteins and membrane proteins. IGFBP also have important IGF-independent 
actions by binding of extracellular membrane proteins and can induce changes in gene 
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expression, metabolism and apoptosis (Marshman & Streuli, 2002; Gluckman et al., 
1987; Baumrucker, 2005; (Yamada and Lee, 2009).  As a result, an increase in IGFBP-3 
by GH may influence the gene expression of MEC, independently of IGF-I.   
 The direct effects of GH and MEC are not fully defined; however, these data 
indicate GH may play a role in regulating the expression of IGFBP-3.  Whether the 
observed changes in IGFBP-3 mRNA abundance are translated into changes in protein 
has yet to be tested.  However, despite the complex relationship of IGFBP-3 with IGF-I 
and MEC, there is an influence of GH over IGFBP-3 mRNA abundance which 
substantiates further investigation into the roles and relevance of the relationships 
between IGFBP-3 and GH and their effects on MEC in vivo.   
  
 
Figure 12: Proposed model of direct effect of GH on primary bovine mammary 
epithelial cells. 
GH stimulates the production of IGF-I by the liver.  IGF-I is a potent growth factor 
which stimulates gene transcription and protein synthesis through its receptor.  The 
direct action of GH on MEC alters the mRNA abundance of IGFBP-3.  IGFBP-3 
binds IGF-I in circulation, it can sequester it from interacting with its receptor, in 
addition to aiding in localization to the receptor through interaction with nearby 
membrane proteins.  By regulating IGFBP-3 mRNA abundance, GH in turn effects 
the systemic availability of IGF-I.  GH: growth hormone, GHR: growth hormone 
receptor, MEC: mammary epithelial cell, IGF-I: insulin-like growth factor-1, IGFR: 
insulin-like growth factor-1 receptor, MP: membrane proteins. 
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Chapter 3 
LIMITATIONS AND CONCLUSIONS 
Limitations and Implications 
Due to culture conditions, the nature of the models utilized, and the limited 
number of animals available, there are several important factors that limit the depth of 
inference of these results.   
Attempts to culture primary MEC and milk derived MEC without the use of FBS 
were unsuccessful.  Particularly in milk derived MEC, the low number of cells obtained 
by each isolation made an initial dense seeding impossible.  Additionally, these cells did 
not proliferate at all without the presence of serum and with serum, adequate proliferation 
took 10-12 days.  It has previously been suggested that due to their lack of in vitro 
proliferation, milk cells must represent a fully differentiated cell type (Boutinaud & 
Jammes, 2002).  As a result of observing poor growth in milk derived MEC and the wide 
spread use of serum reported in the literature, primary MEC were always cultured with 
serum.  Even with the addition of serum, primary cells exhibited better proliferation than 
milk derived cells.  Investigation into the requirements of serum for both primary and 
milk derived MEC may prove useful in designing future experiments. 
In addition to limited proliferation without serum, unknown quantities of growth 
factors and other proteins present in serum represent a confounding variable.  
Additionally, because GH is present in serum, it is difficult to determine the actual dose 
of GH during experimentation.  However, despite unknown concentrations of GH, serum 
lots were the same for each experiment.  During the course of these experiments, 
charcoal-stripped serum was not used.  In light of these limitations, it may be useful in 
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future to evaluate primary cell proliferation with charcoal-filtered serum and use it during 
future experiments.  If primary cells fail to proliferate using charcoal-stripped serum, it 
may be appropriate to use standard serum during proliferation and charcoal-stripped 
during experimentation. 
Given the concern of the addition of an unquantified amount GH through the use 
of serum in addition to the treatment concentration of 10ng/mL, it may also be useful to 
evaluate a dose-response curve for GH in primary cells.  GH concentrations in serum can 
vary between 4.1-167ng/mL (Honn et al., 1975).  The treatment value (10ng/mL GH) of 
GH in this study was selected based on previous dose-response curves in MAC-T and 
values reported in the literature (Johnson et al., 2010). 
Considering the integrated role GH and IGF-I play in vivo, evaluating their 
synergistic effects on IGFBP-3 in primary MEC would lend clarity to the proposed model 
and the observed differences between dairy breeds.   
MEC populations for these experiments were all derived from the campus dairy 
herd.  For milk-derived cells, milk was pooled from four dairy cows and a total of 800mL 
of milk could be collected at one time.  These limitations were a result of the equipment 
available and feasibility of time.  The centrifuge used was capable of holding 800mL of 
contents and the time required to obtain the milk samples became a limiting factor in 
order to quickly return to the laboratory and begin isolating MEC.  As a result, only a 
small number of MEC were able to be collected at one time.  By collecting a larger 
volume of raw milk, a larger initial population of MEC could be collected with which to 
begin experiments.  Additionally, because milk was collected from a small number of 
animals, it is difficult to draw inferences that apply to breeds as a whole. 
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For explants and primary MEC, only two animals were used for this study (one 
each of Holstein and Jersey).  Because all primary cells from each breed were originally 
derived from the same animal, it is difficult to extrapolate results obtained from these two 
individual animals to their respective breed populations as a whole.  However, although 
only one animal was used for the initial isolation, the experiment was replicated three 
times.  Additionally, most cells lines, MAC-T in particular, also originate from cells 
isolated from one individual.  Despite this, MAC-T have been widely used to model 
bovine MEC in vitro.  However, it is common to validate results obtained from cells lines 
by evaluating primary models.  Therefore, in this study using primary cells that have not 
been widely studied, it would have been valuable to have more individuals from which to 
obtain samples to aid in reducing the impact that individual variations in genotype, health 
status, and stage of lactation may play in this model.  It is important to note, though, that 
the pattern of IGFBP-3 abundance in response to GH was similar between MEC from the 
same breed, regardless of the isolation technique used.  Although the sample size in this 
study was low, different MEC models obtained from different animals showed the same 
pattern of response to GH across breeds.  This lends support to the claim that GH has 
differing effects between Jerseys and Holsteins. 
In spite of these limitations, these results remain valuable initial data that can 
serve to guide future investigations.  Future studies utilizing these primary models would 
benefit from the availability of more sample animals, particularly animals at the same 
stage of lactation, and perhaps a broader collection of samples beyond the campus herd.  
Increased sampling would more accurately represent the response of breeds as a whole, 
and not only the isolated population in the campus herd. 
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Conclusion 
  In consideration of this study’s limitations, further investigation is required in 
order to convincingly describe the proposed model of the direct effect of GH and its 
potential regulation of IGFBP-3.  Differences observed between breeds were conserved 
across all models evaluated, although not at the same magnitude.  Additionally, these 
conclusions have been drawn from mRNA abundance data and it is critical to verify if 
these differences in mRNA abundance are still present in protein abundance.  It is also 
important to note that there are other regulators of IGFBP-3 in vivo that were not 
measured here.  Investigation into any effect GH may play on other regulators of IGFBP-
3 may yield a more complete, and accurate, model of the direct role of GH. 
The reported results taken with consideration of their limitations provide a useful 
potential model of the direct role of GH on bovine MEC.  Although extrapolation of these 
results to whole populations is difficult, it provides a plausible explanation of one of the 
differences between Jersey and Holstein cattle’s response to GH. 
  
59 
Literature Cited 
Akers RM 1985 Lactogenic hormones - binding-sites, mammary growth, secretory-cell 
differentiation, and milk biosynthesis in ruminants. Journal of Dairy Science 68(2) 
501-519 
Akers RM 2006 Major advances associated with hormone and growth factor regulation 
of mammary growth and lactation in dairy cows. Journal of Dairy Science 89(4) 
1222-1234 
Akers RM, McFadden TB, Purup S, Vestergaard M, Sejrsen K & Capuco AV 2000 
Local IGF-I axis in peripubertal ruminant mammary development. Journal of 
Mammary Gland Biology and Neoplasia 5(1) 43-51 
Alberts B, Johnson A, Lewis J, Raff M, Roberts K & Walter P 2008 Molecular 
Biology of the Cell. 5th Edition.: Garland Science, Taylor & Francis Group, LLC. 
Aslakson CJ & Miller FR 1992 Selective events in the metastatic process defined by 
analysis of the sequential dissemination of subpopulations of a mouse mammary 
tumor. Cancer Research 52(6) 1399-1405 
Ball RK, Friis RR, Schoenenberger CA, Doppler W & Groner B 1988 Prolactin 
regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a 
cloned mouse mammary epithelial cell line. EMBO J 7(7) 2089-2095 
Barclay JL, Kerr LM, Arthur L, Rowland JE, Nelson CN, Ishikawa M, d'Aniello 
EM, White M, Noakes PG & Waters MJ 2010 In Vivo Targeting of the Growth 
Hormone Receptor (GHR) Box1 Sequence Demonstrates that the GHR Does Not 
Signal Exclusively through JAK2. Molecular Endocrinology 24(1) 204-217 
Baserga R, Peruzzi F & Reiss K 2003 The IGF-1 receptor in cancer biology. 107 873-
877 
Bauman DE & Currie WB 1980 Partitioning of nutrients during pregnancy and 
lactation - a review of mechanisms involving homeostasis and homeorhesis. Journal 
of Dairy Science 63(9) 1514-1529 
Bauman DE & Vernon RG 1993 Effects of exogenous bovine somatotropin on 
lactation. Annual Review of Nutrition 13 437-461 
Baumrucker CR 2005 Intracrine signaling in the mammary gland. Livestock Production 
Science 98(1-2) 47-56 
Baumrucker CR & Erondu NE 2000 Insulin-like growth factor (IGF) system in the 
bovine mammary gland and milk. Journal of Mammary Gland Biology and Neoplasia 
5(1) 53-64 
Baxter F, Neoh K & Tevendale M 2007 The Beginning of the End: Death Signaling in 
Early Involution. Journal of Mammary Gland Biology and Neoplasia 12(1) 3-13 
Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L & Hintz RL 1981 
Somatomedin-C Mediates Growth Hormone Negative Feedback by Effects on Both 
the Hypothalamus and the Pituitary. Science 212(4500) 1279-1281 
60 
Berry SD, McFadden TB, Pearson RE & Akers RM 2001 A local increase in the 
mammary IGF-1: IGFBP-3 ratio mediates the mammogenic effects of estrogen and 
growth hormone. Domestic Animal Endocrinology 21(1) 39-53 
Bolander FF 1989 Molecular endocrinology. Academic Press 
Boutinaud M, Ben Chedly MH, Delamaire E & Guinard-Flament J 2008 Milking 
and feed restriction regulate transcripts of mammary epithelial cells purified from 
milk. Journal of Dairy Science 91(3) 988-998 
Boutinaud M & Jammes H 2002 Potential uses of milk epithelial cells: a review. 
Reproduction Nutrition Development 42(2) 133-147 
Boutinaud M, Rulquin H, Keisler DH, Djiane J & Jammes H 2002 Use of somatic 
cells from goat milk for dynamic studies of gene expression in the mammary gland. 
Journal of Animal Science 80(5) 1258-1269 
Braun JEA & Severson DL 1992 Regulation of the synthesis, processing and 
translocation of lipoprotein-lipase. Biochemical Journal 287 337-347 
Brennan AJ, Sharp JA, Lefevre CM & Nicholas KR 2008 Uncoupling the 
mechanisms that facilitate cell survival in hormone-deprived bovine mammary 
explants. J Mol Endocrinol 41(3) 103-116 
Brisken C, Ayyannan A, Nguyen C, Heineman A, Reinhardt F, Jan T, Dey SK, 
Dotto GP & Weinberg RA 2002 IGF-2 Is a Mediator of Prolactin-Induced 
Morphogenesis in the Breast. Developmental cell 3(6) 877-887 
Brisken C & O'Malley B 2010 Hormone action in the Mammary Gland. Cold Spring 
Harbor Perspectives in Biology 2 
Buehring GC 1990 Culture of mammary epithelial-cells from bovine-milk. Journal of 
Dairy Science 73(4) 956-963 
Butler AA & Le Roith D 2001 Control of growth by the somatropic axis: Growth 
hormone and the insulin-like growth factors have related and independent roles. 
Annual Review of Physiology 63 141-164 
Campbell PG 1988 Insulin-like growth factor-I and insulin-like growth factor binding 
proteins in the bovine mammary gland: Receptors, endogenous secretion, and 
appearance in milk.  
Campbell PG, Skaar TC, Vega JR & Baumrucker CR 1991 Secretion of insulin-like 
growth factor-1 (IGF-1) and IGF-binding proteins from bovine mammary tissue in 
vitro. Journal of Endocrinology 128(2) 219-228 
Capper JL, Cady RA & Bauman DE 2009 Increased production reduces the dairy 
industry's environmental impact. Proceedings of the 18th Annual Tri-State Dairy 
Nutrition Conference, Fort Wayne, Indiana, USA, 21-22 April, 2009  71-82 
Capper JL, Castaneda-Gutierrez E, Cady RA & Bauman DE 2008 The 
environmental impact of recombinant bovine somatotropin (rbST) use in dairy 
production. Proceedings of the National Academy of Sciences of the United States of 
America 105(28) 9668-9673 
61 
Carstens GE, Glaser DE, Byers FM, Greene LW & Lunt DK 1997 Effects of bovine 
somatotropin treatment and intermittent growth pattern on mammary gland 
development in heifers. Journal of Animal Science 75(9) 2378-2388 
CarterSu C, Schwartz J & Smit LS 1996 Molecular mechanism of growth hormone 
action. Annual Review of Physiology 58 187-207 
Ceriani R, Taylor-Papadimitriou J, Peterson J & Brown P 1979 Characterization of 
cells cultured from early lactation milks. In Vitro Cellular &amp; Developmental 
Biology - Plant 15(5) 356-362 
Ceriani RL 1974 Hormones and other factors controlling growth in mammary-gland - 
review. Journal of Investigative Dermatology 63(1) 93-108 
Cohick WS 1998 Role of the insulin-like growth factors and their binding proteins in 
lactation. Journal of Dairy Science 81(6) 1769-1777 
Cohick WS & Clemmons DR 1993 The insulin-like growth-factors. Annual Review of 
Physiology 55 131-153 
Cohick WS & Turner JD 1998 Regulation of IGF binding protein synthesis by a bovine 
mammary epithelial cell line. Journal of Endocrinology 157(2) 327-336 
Collier R, McGrath MF & Vincini JL 1999 Somatotropin and the U.S. dairy industry. 
Medecin Veterinaire du Quebec 29(2) 89-92 
Cotes P, Crichton J, Folley S & Young F 1949 Galactopoietic activity of purified 
anterior pituitary growth hormone. Nature 164(4180) 992-993 
Dahl GE, Chapin LT, Allen MS, Moseley WM & Tucker HA 1991 Comparison of 
somatotropin and growth hormone-releasing factor on milk-yield, serum hormones, 
and energy status. Journal of Dairy Science 74(10) 3421-3428 
Daniel CW & Smith GH 1999 The mammary gland: A model for development. Journal 
of Mammary Gland Biology and Neoplasia 4(1) 3-8 
Danielson KG, Oborn CJ, Durban EM, Butel JS & Medina D 1984 Epithelial mouse 
mammary cell line exhibiting normal morphogenesis in vivo and functional 
differentiation in vitro. Proceedings of the National Academy of Sciences 81(12) 
3756-3760 
Dulbecco R, Bologna M & Unger M 1979 Differentiation of a rat mammary cell-line in 
vitro. Proceedings of the National Academy of Sciences of the United States of 
America 76(3) 1256-1260 
Ebner KE, Hoover CR, Hageman EC & Larson BL 1961 Cultivation and properties of 
bovine mammary cell cultures. Experimental Cell Research 23(2) 373-385 
Eppard PJ, Bentle LA, Violand BN, Ganguli S, Hintz RL, Kung L, Krivi GG & 
Lanza GM 1992 Comparison of the galactopoietic response to pituitary-derived and 
recombinant-derived variants of bovine growth hormone. Journal of Endocrinology 
132(1) 47-56 
62 
Ernens I, Clegg R, Schneider YJ & Larondelle Y 2007 Short communication: Ability 
of cultured mammary epithelial cells in a bicameral system to secrete milk fat. 
Journal of Dairy Science 90(2) 677-681 
Etherton TD & Bauman DE 1998 Biology of somatotropin in growth and lactation of 
domestic animals. Physiological Reviews 78(3) 745-761 
Fleming JM, Leibowitz BJ, Kerr DE & Cohick WS 2005 IGF-I differentially regulates 
IGF-binding protein expression in primary mammary fibroblasts and epithelial cells. 
Journal of Endocrinology 186(1) 165-178 
Flint DJ, Beattie J & Allan GJ 2003 Modulation of the actions of IGFs by IGFBP-5 in 
the mammary gland. Hormone and Metabolic Research 35(11-12) 809-815 
Flint DJ & Knight CH 1997 Interactions of prolactin and growth hormone (GH) in the 
regulation of mammary gland function and epithelial cell survival. Journal of 
Mammary Gland Biology and Neoplasia 2(1) 41-48 
Gaffney EV 1982 A cell-line (HBL-100) established from human-breast milk. Cell and 
Tissue Research 227(3) 563-568 
Gibson CA, Staley MD & Baumrucker CR 1999 Identification of IGF binding proteins 
in bovine milk and the demonstration of IGFBP-3 synthesis and release by bovine 
mammary epithelial cells. Journal of Animal Science 77(6) 1547-1557 
Gibson JP, van der Meulen M, McBride BW & Burton JH 1992 The Effects of 
Genetic and Phenotypic Production Potential on Response to Recombinant Bovine 
Somatotropin. Journal of Dairy Science 75(3) 878-884 
Glimm DR, Baracos VE & Kennelly JJ 1990 Molecular evidence for the presence of 
growth-hormone receptors in the bovine mammary-gland. Journal of Endocrinology 
126(3) R5-R8 
Gluckman PD, Breier BH & Davis SR 1987 Physiology of the Somatotropic Axis with 
Particular Reference to the Ruminant. Journal of Dairy Science 70(2) 442-466 
Gorewit RC, Svennersten K, Butler WR & Uvnasmoberg K 1992 Endocrine 
responses in cows milked by hand and machine. Journal of Dairy Science 75(2) 443-
448 
Grant DS, Kleinman HK, Leblond CP, Inoue S, Chung AE & Martin GR 1985 The 
basement-membrane-like matrix of the mouse ehs tumor .2. Immunohistochemical 
quantitation of 6 of its components. American Journal of Anatomy 174(4) 387-398 
Hauser SD, McGrath MF, Collier RJ & Krivi GG 1990 Cloning and in vivo 
expression of bovine growth-hormone receptor messenger-RNA. Molecular and 
Cellular Endocrinology 72(3) 187-200 
Honn, K., Singley J, & Chavin W 1975 Fetal Bovine Serum: A Multivariate Standard. 
Experimental Biology and Medicine 149: 344-347. 
Hovey RC, Harris J, Hadsell DL, Lee AV, Ormandy CJ & Vonderhaar BK 2003 
Local insulin-like growth factor-II mediates prolactin-induced mammary gland 
development. Molecular Endocrinology 17(3) 460-471 
63 
Hovey RC, Trott JF & Vonderhaar BK 2002 Establishing a Framework for the 
Functional Mammary Gland: From Endocrinology to Morphology. Journal of 
Mammary Gland Biology and Neoplasia 7(1) 17-38 
Hutton JB 1957 The effect of growth hormone on the yield and composition of cows 
milk. Journal of Endocrinology 16(2) 115-125 
Huynh HT, Robitaille G & Turner JD 1991 Establishment of bovine mammary 
epithelial-cells (MAC-T) - an in vitro model for bovine lactation. Experimental Cell 
Research 197(2) 191-199 
Ip MM & Darcy KM 1996 Three-dimensional mammary primary culture model 
systems. Journal of Mammary Gland Biology and Neoplasia 1(1) 91-110 
Johnson T 2010 Growth hormone alters components related to differentiation, 
metabolism and milk synthesis and secretion in MAC-T cells. Vol. MS. California 
Polytechnic State University 
Johnson TL, Fujimoto BAS, Jimenez-Flores R & Peterson DG 2010 Growth hormone 
alters lipid composition and increases the abundance of casein and lactalbumin 
mRNA in the MAC-T cell line. Journal of Dairy Research 77(2) 199-204 
Kawano A, Tateyama S, Yamaguchi R, Nosaka D & Kondo F 1988 Morphology of 
goat milk-derived mammary epithelial cells cultured in collagen gel. Nippon Juigaku 
Zasshi 50(6) 1252-1258 
Keenan TW 2001 Assembly and secretion of the lipid globules of milk. Bioactive 
Components of Human Milk 501 125-136 
Keys J, Cifrian E, Guidry A & Farrell H 1997 Bovine mammary explant versus 
primary cell cultures: Effect of bovine somatotropin and insulinlike growth factor-I 
on DNA content and protein synthesis. In Vitro Cellular &amp; Developmental 
Biology - Animal 33(3) 206-211 
Keys JE, Fekry AE, Wood DL & Capuco AV 1992 The ability of bovine mammary 
tissue to synthesize lipids for 96-h when co-cultured with liver and adipose-tissue. 
Biochemistry and Cell Biology-Biochimie Et Biologie Cellulaire 70(5) 343-346 
Kleinberg D & Ruan WF 2008 IGF-I, GH, and Sex Steroid Effects in Normal 
Mammary Gland Development. Journal of Mammary Gland Biology and Neoplasia 
13(4) 353-360 
Kleinberg DL 1997 Early mammary development: growth hormone and IGF-1. J 
Mammary Gland Biol Neoplasia 2(1) 49-57 
Knight CH 2000 Mammary gland development and function. The health of dairy cattle.  
203-212 
Knight CH 2001 Overview of prolactin's role in farm animal lactation. Livestock 
Production Science 70(1-2) 87-93 
Kopchick JJ & Andry JM 2000 Growth hormone (GH), GH receptor, and signal 
transduction. Molecular Genetics and Metabolism 71(1-2) 293-314 
64 
Kresge N & Simoni RD 2006 Lactose Synthesis in the Mammary Gland: Lactose 
Synthase and the Work of Robert L. Hill. Journal of Biological Chemistry 281(6) e6 
Kulik G, Klippel A & Weber MJ 1997 Antiapoptotic signalling by the insulin-like 
growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Molecular and 
Cellular Biology 17(3) 1595-1606 
Kumar S, Clarke AR, Hooper ML, Horne DS, Law AJR, Leaver J, Springbett A, 
Stevenson E & Simons JP 1994 Milk-composition and lactation of beta-casein-
deficient mice. Proceedings of the National Academy of Sciences of the United States 
of America 91(13) 6138-6142 
Larson BL 1969 Biosynthesis of Milk. Journal of Dairy Science 52(5) 737-747 
Larson BL & Smith VR 1974 Lactation: a comprehensive treatise, edited by Bruce L. 
Larson and Vearl R. Smith. New York: Academic Press 
Le Roith D, Bondy C, Yakar S, Liu J-L & Butler A 2001 The Somatomedin 
Hypothesis: 2001. Endocrine Reviews 22(1) 53-74 
Lee MO & Schaffer NK 1934 Anterior Pituitary Growth Hormone and the Composition 
of Growth. The Journal of Nutrition 7(3) 337-363 
Leroith D, Werner H, Beitnerjohnson D & Roberts CT 1995 Molecular and cellular 
aspects of the insulin-like growth-factor-i receptor. Endocrine Reviews 16(2) 143-163 
Li ML, Liu XW, Robinson G, BarPeled U, Wagner KU, Young WS, Hennighausen 
L & Furth PA 1997 Mammary-derived signals activate programmed cell death 
during the first stage of mammary gland involution. Proceedings of the National 
Academy of Sciences of the United States of America 94(7) 3425-3430 
Liu XW, Robinson GW, Wagner KU, Garrett L, WynshawBoris A & Hennighausen 
L 1997 Stat5a is mandatory for adult mammary gland development and lactogenesis. 
Genes & Development 11(2) 179-186 
Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real-
time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 25(4) 402-408 
Lonnerdal B 2007 Trace element transport in the mammary gland. Annual Review of 
Nutrition 27 165-177 
Malinowski E 2005 Mammary gland involution in cows. Medycyna Weterynaryjna 
61(9) 968-971 
Mallepell S, Krust Ae, Chambon P & Brisken C 2006 Paracrine signaling through the 
epithelial estrogen receptor Î± is required for proliferation and morphogenesis in the 
mammary gland. Proceedings of the National Academy of Sciences of the United 
States of America 103(7) 2196-2201 
Marshman E & Streuli CH 2002 Insulin-like growth factors and insulin-like growth 
factor binding proteins in mammary gland function. Breast Cancer Research 4(6) 
231-239 
65 
Marti A, Jehn B, Costello E, Keon N, Ke G, Martin F & Jaggi R 1994 Protein kinase-
a and ap-1 (c-fos/jund) are induced during apoptosis of mouse mammary epithelial-
cells. Oncogene 9(4) 1213-1223 
Mather IH & Keenan TW 1998 Introduction - The cell biology of milk secretion: 
Historical notes. Journal of Mammary Gland Biology and Neoplasia 3(3) 227-232 
Matitashvili E & Bauman DE 1999 Culture of primary bovine mammary epithelial 
cells. In Vitro Cellular & Developmental Biology-Animal 35(8) 431-434 
McDowell GH, Gooden JM, Leenanuruksa D, Jois M & English AW 1987 Effects of 
exogenous growth-hormone on milk-production and nutrient-uptake by muscle and 
mammary tissues of dairy-cows in midlactation. Australian Journal of Biological 
Sciences 40(3) 295-306 
McGuire MA, Vicini JL, Bauman DE & Veenhuizen JJ 1992 Insulin-like growth-
factors and binding-proteins in ruminants and their nutritional regulation. Journal of 
Animal Science 70(9) 2901-2910 
McManaman JL & Neville MC 2003 Mammary physiology and milk secretion. 
Advanced Drug Delivery Reviews 55(5) 629-641 
Menzies KK, Lefevre C, Macmillan KL & Nicholas KR 2009 Insulin regulates milk 
protein synthesis at multiple levels in the bovine mammary gland. Functional & 
Integrative Genomics 9(2) 197-217 
Mills ES & Topper YJ 1970 Some ultrastructural effects of insulin, hydrocortisone, and 
prolactin on mammary gland explants. Journal of Cell Biology 44(2) 310-& 
Murrieta CM, Hess BW, Scholljegerdes EJ, Engle TE, Hossner KL, Moss GE & 
Rule DC 2006 Evaluation of milk somatic cells as a source of mRNA for study of 
lipogenesis in the mammary gland of lactating beef cows supplemented with dietary 
high-linoleate safflower seeds. Journal of Animal Science 84(9) 2399-2405 
Nytes AJ, Combs DK, Shook GE, Shaver RD & Cleale RM 1990 Response to 
Recombinant Bovine Somatotropin in Dairy Cows with Different Genetic Merit for 
Milk Production. Journal of Dairy Science 73(3) 784-791 
Peel CJ & Bauman DE 1987 Somatotropin and lactation. Journal of Dairy Science 70(2) 
474-486 
Peel CJ, Bauman DE, Gorewit RC & Sniffen CJ 1981 Effect of exogenous growth-
hormone on lactational performance in high yielding dairy-cows. Journal of Nutrition 
111(9) 1662-1671 
Piwien-Pilipuk G, Huo JS & Schwartz J 2002 Growth hormone signal transduction. 
Journal of Pediatric Endocrinology & Metabolism 15(6) 771-786 
Plath-Gabler A, Gabler C, Sinowatz F, Berisha B & Schams D 2001 The expression 
of the IGF family and GH receptor in the bovine mammary gland. Journal of 
Endocrinology 168(1) 39-48 
66 
Pocius PA & Herbein JH 1986 Effects of in vivo administration of growth-hormone on 
milk-production and in vitro hepatic-metabolism in dairy-cattle. Journal of Dairy 
Science 69(3) 713-720 
Richards J, Larson L, Yang J, Guzman R, Tomooka Y, Osborn R, Imagawa W & 
Nandi S 1983 Method for culturing mammary epithelial cells in a rat tail collagen gel 
matrix. Methods in Cell Science 8(1) 31-36 
Richert MM, Schwertfeger KL, Ryder JW & Anderson SM 2000 An atlas of mouse 
mammary gland development. Journal of Mammary Gland Biology and Neoplasia 
5(2) 227-241 
Riley LG, Gardiner-Garden M, Thomson PC, Wynn PC, Williamson P, Raadsma 
HW & Sheehy PA 2010 The influence of extracellular matrix and prolactin on global 
gene expression profiles of primary bovine mammary epithelial cells in vitro. Animal 
Genetics 41(1) 55-63 
Riley LG, Williamson P, Wynn PC & Sheeh PA 2008 Lactoferrin decreases primary 
bovine mammary epithelial cell viability and casein expression. Journal of Dairy 
Research 75(2) 135-141 
Robinson GW, McKnight RA, Smith GH & Hennighausen L 1995 Mammary 
epithelial cells undergo secretory differentiation in cycling virgins but require 
pregnancy for the establishment of terminal differentiation. Development 121(7) 
2079-2090 
Rohlfs EM, Louie DS & Zeisel SH 1993 Lipid-synthesis and secretion by primary 
cultures of rat mammary epithelial-cells. Journal of Cellular Physiology 157(3) 469-
480 
Rosen JM, Wyszomierski SL & Hadsell D 1999 Regulation of milk protein gene 
expression. Annual Review of Nutrition 19 407-436 
Rowzee AM, Ludwig DL & Wood TL 2009 Insulin-Like Growth Factor Type 1 
Receptor and Insulin Receptor Isoform Expression and Signaling in Mammary 
Epithelial Cells. Endocrinology 150(8) 3611-3619 
Ruan WF & Kleinberg DL 1999 Insulin-like growth factor I is essential for terminal 
end bud formation and ductal morphogenesis during mammary development. 
Endocrinology 140(11) 5075-5081 
Sakamoto K, Komatsu T, Kobayashi T, Rose MT, Aso H, Hagino A & Obara Y 
2005 Growth hormone acts on the synthesis and secretion of alpha-casein in bovine 
mammary epithelial cells. Journal of Dairy Research 72(3) 264-270 
Sakamoto K, Yano T, Kobayashi T, Hagino A, Aso H & Obara Y 2007 Growth 
hormone suppresses the expression of IGFBP-5, and promotes the IGF-I-induced 
phosphorylation of Akt in bovine mammary epithelial cells. Domestic Animal 
Endocrinology 32(4) 260-272 
Schmidt GH 1971 Biology of Lactation. Books on Demand 
67 
Sejrsen K, Foldager J, Sorensen MT, Akers RM & Bauman DE 1986 Effect of 
exogenous bovine somatotropin on pubertal mammary development in heifers. 
Journal of Dairy Science 69(6) 1528-1535 
Sejrsen K, Hvelplund T & Nielsen MO 2006 Ruminant physiology: digestion, 
metabolism and impact of nutrition on gene expression, immunology and stress. Xth 
International Symposium on Ruminant Physiology, Copenhagen, Denmark, 
September 2004. Ruminant physiology: digestion, metabolism and impact of nutrition 
on gene expression, immunology and stress. Xth International Symposium on 
Ruminant Physiology, Copenhagen, Denmark, September 2004.  600 pp. 
Shafiei F, Herington AC & Lobie PE 2006 Mechanisms of signal transduction utilized 
by growth hormone.  (Elsevier 
Sheehy PA, Della-Vedova JJ, Nicholas KR & Wynn PC 2004 Hormone-dependent 
milk protein gene expression in bovine mammary explants from biopsies at different 
stages of pregnancy. Journal of Dairy Research 71(2) 135-140 
Sheffield LG 1988 Organization and growth of mammary epithelia in the mammary-
gland fat pad. Journal of Dairy Science 71(10) 2855-2874 
Shennan DB & Peaker M 2000 Transport of milk constituents by the mammary gland. 
Physiological Reviews 80(3) 925-951 
Soule HD, Vazquez J, Long A, Albert S & Brennan M 1973 A human cell line from a 
pleural effusion derived from a breast carcinoma. Journal of the National Cancer 
Institute 51(5) 1409-1416 
Stewart CEH & Rotwein P 1996 Growth, differentiation, and survival: Multiple 
physiological functions for insulin-like growth factors. Physiological Reviews 76(4) 
1005-1026 
Stoker M & Perryman M 1984 Cultures of exfoliated mammary epithelial cells: 
Variation between donors. Breast Cancer Research and Treatment 4(1) 11-18 
Suard Y, Haeuptle M, Farinon E & Kraehenbuhl J 1983 Cell proliferation and milk 
protein gene expression in rabbit mammary cell cultures. The Journal of Cell Biology 
96(5) 1435-1442 
Svennersten-Sjaunja K & Olsson K 2005 Endocrinology of milk production. Domestic 
Animal Endocrinology 29(2) 241-258 
Takeishi M, Nakamura S, Tsumagari S, Shibata M, Okuda M, Ishii T, Tsunekane T 
& Yosai A 1980 Studies on the development of mammary gland in bovine fetuses. 
Japanese Journal of Animal Reproduction 26(3) 134-137 
Taketani Y & Oka T 1981 Hormonal induction of milk protein-synthesis in primary 
mammary epithelial-cell culture. Journal of Cell Biology 91(2) A217-A217 
Tateyama S, Kawano A, Yamaguchi R, Nosaka D & Kondo F 1988 Culture 
conditions and cell morphology of goat milk-derived mammary epithelial cells in 
plate culture. Nippon Juigaku Zasshi 50(6) 1192-1199 
68 
Taylor-Papadimitriou J, Shearer M & Stoker MGP 1977 Growth requirements of 
human mammary epithelial cells in culture. In Book Growth requirements of human 
mammary epithelial cells in culture, Vol. 20, pp. 903-908 (Ed.^Eds. Editor).Series 
Growth requirements of human mammary epithelial cells in culture. Wiley 
Subscription Services, Inc., A Wiley Company 
Topper YJ & Freeman CS 1980 Multiple hormone interactions in the developmental 
biology of the mammary gland. Physiological Reviews 60(4) 1049-1106 
Truchet S & Ollivier-Bousquet M 2009 Mammary gland secretion: hormonal 
coordination of endocytosis and exocytosis. animal 3(12) 1733-1742 
Tuggle CK & Trenkle A 1996 Control of growth hormone synthesis. Domestic Animal 
Endocrinology 13(1) 1-33 
West JW, Bondari K & Johnson JC 1990 Effects of bovine somatotropin on milk-yield 
and composition, body-weight, and condition score of Holstein and Jersey cows. 
Journal of Dairy Science 73(4) 1062-1068 
Wheeler TT, Callaghan MR, Davis SR, Prosser CG & Wilkins RJ 1995 Milk Protein 
Synthesis, Gene Expression, and Hormonal Responsiveness in Primary Cultures of 
Mammary Cells from Lactating Sheep. Experimental Cell Research 217(2) 346-354 
Wilde CJ, Peaker M & Knight CH 1995 Intercellular signalling in the mammary gland. 
Plenum Press 
Yamada PM & Lee K-W 2009 Perspectives in mammalian IGFBP-3 biology: local vs. 
systemic action. American Journal of Physiology - Cell Physiology 296(5) C954-
C976 
Zhao FQ, Okine EK & Kennelly JJ 1999 Glucose transporter gene expression in 
bovine mammary gland. Journal of Animal Science 77(9) 2517-2522 
Zhou Y, Akers RM & Jiang H 2008 Growth hormone can induce expression of four 
major milk protein genes in transfected MAC-T cells. Journal of Dairy Science 91(1) 
100-108 
 
69 
Appendix 
QUANTITATIVE PCR DATA 
Raw data from quantitative PCR is presented in the following appendix.  Briefly, 
raw CT values were normalized to the indicated house-keeping gene (HKG).  The raw 
HKG CT value was subtracted from the gene target’s raw CT value as an absolute value, 
yielding the CT.  The 2
-CT method was used to calculate abundance.  The 2-CT 
value was averaged within the treatment group and a standard error of the mean (SEM) 
was calculated. 
Mammary explants from a Jersey cow (Tables 1-5): raw qPCR values 
corresponding to results presented in Figure 4. 
 
 
Appendix Table 1: Q-PCR raw CT values and calculations for -lactalbumin mRNA 
abundance in mammary explants from a Jersey cow cultured for 12 h. 
 
Sample ID CT HKG ID CT CT 2-CT Average SEM
ALAC 1 23.3877 TBP 1 30.7681 7.38040 0.006002
ALAC 2 19.7817 TBP 2 31.6413 11.85960 0.000269
ALAC 3 20.0330 TBP 3 30.0357 10.00270 0.000975
ALAC 6 18.9668 TBP 6 30.3789 11.41210 0.000367
ALAC 7 22.0721 TBP 7 30.2745 8.20240 0.003395
ALAC 8 20.3920 TBP 8 30.8261 10.43410 0.000723
ALAC 10 22.2297 TBP 10 31.0763 8.84660 0.002172
ALAC 13 26.8911 TBP 13 29.9393 3.04820 0.120893
ALAC 15 27.3917 TBP 15 31.2600 3.86830 0.068474
ALAC 16 23.4633 TBP 16 30.0017 6.53840 0.010758
ALAC 18 26.9977 TBP 18 29.8854 2.88770 0.135119
D
IP
D
IP
+
G
H
0.001955 0.000936
0.0273050.067483
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Appendix Table 2: Q-PCR raw CT values and calculations for s1-casein mRNA 
abundance in mammary explants from a Jersey cow cultured for 12 h. 
 
 
Appendix Table 3: Q-PCR raw CT values and calculations for GH receptor mRNA 
abundance in mammary explants from a Jersey cow cultured for 12 h. 
 
Sample ID CT HKG ID CT CT 2-CT Average SEM
CAS 1 18.4718 TBP 1 30.7681 12.29630 0.000199
CAS 2 16.9761 TBP 2 31.6413 14.66520 0.000038
CAS 5 22.8326 TBP 5 30.3654 7.53280 0.005400
CAS 11 18.6314 TBP 11 29.9068 11.27540 0.000403
CAS 12 16.4670 TBP 12 30.3710 13.90400 0.000065
CAS 13 20.0431 TBP 13 29.9393 9.89620 0.001049
CAS 14 15.8211 TBP 14 30.0381 14.21700 0.000053
CAS 15 22.9361 TBP 15 31.2600 8.32390 0.003121
D
IP
D
IP
+
G
H
0.001879 0.001761
0.0005750.000938
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
GHR 1 26.6222 TBP 1 30.7681 4.14590 0.056488
GHR 2 26.8406 TBP 2 31.6413 4.80070 0.035879
GHR 3 27.613 TBP 3 30.0357 2.42270 0.186507
GHR 4 25.96 TBP 4 30.7241 4.76410 0.036801
GHR 5 29.6131 TBP 5 30.3654 0.75230 0.593656
GHR 6 26.3811 TBP 6 30.3789 3.99780 0.062595
GHR 7 26.6273 TBP 7 30.2745 3.64720 0.079815
GHR 8 25.5178 TBP 8 30.8261 5.30830 0.025237
GHR 10 28.9397 TBP 10 31.0763 2.13660 0.227415
GHR 11 26.0177 TBP 11 29.9068 3.88910 0.067494
GHR 12 25.128 TBP 12 30.371 5.24300 0.026406
GHR 13 26.3044 TBP 13 29.9393 3.63490 0.080498
GHR 14 25.9939 TBP 14 30.0381 4.04420 0.060614
GHR 15 30.1589 TBP 15 31.26 1.10110 0.466161
GHR 16 26.9681 TBP 16 30.0017 3.03360 0.122122
GHR 17 28.3196 TBP 17 31.1174 2.79780 0.143806
GHR 18 26.5253 TBP 18 29.8854 3.36010 0.097389
0.134622 0.068005D
IP
D
IP
+
G
H
0.0464880.143545
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Appendix Table 4: Q-PCR raw CT values and calculations for IGF-I mRNA abundance in 
mammary explants from a Jersey cow cultured for 12 h. 
 
 
Appendix Table 5: Q-PCR raw CT values and calculations for IGFBP3 mRNA abundance 
in mammary explants from a Jersey cow cultured for 12 h. 
 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGF-1 1 28.1265 TBP 1 30.7681 2.64160 0.160250
IGF-1 2 28.7227 TBP 2 31.6413 2.91860 0.132256
IGF-1 6 28.0533 TBP 6 30.3789 2.32560 0.199492
IGF-1 7 27.2523 TBP 7 30.2745 3.02220 0.123091
IGF-1 8 27.5631 TBP 8 30.8261 3.26300 0.104169
IGF-1 11 26.1650 TBP 11 29.9068 3.74180 0.074749
IGF-1 12 26.5807 TBP 12 30.3710 3.79030 0.072278
IGF-1 13 26.8985 TBP 13 29.9393 3.04080 0.121514
IGF-1 15 29.4842 TBP 15 31.2600 1.77580 0.292032
IGF-1 16 27.7479 TBP 16 30.0017 2.25380 0.209671
IGF-1 17 28.9910 TBP 17 31.1174 2.12640 0.229029
IGF-1 18 26.4006 TBP 18 29.8854 3.48480 0.089325
0.143852
0.155514
D
IP
D
IP
+
G
H
0.016590
0.033081
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGFBP3 1 24.028 TBP 1 30.7681 6.74010 0.009355
IGFBP3 2 24.1119 TBP 2 31.6413 7.52940 0.005413
IGFBP3 3 23.7328 TBP 3 30.0357 6.30290 0.012666
IGFBP3 4 23.158 TBP 4 30.7241 7.56610 0.005277
IGFBP3 6 24.0665 TBP 6 30.3789 6.31240 0.012583
IGFBP3 12 23.0041 TBP 12 30.371 7.36690 0.006058
IGFBP3 13 24.0115 TBP 13 29.9393 5.92780 0.016427
IGFBP3 14 23.288 TBP 14 30.0381 6.75010 0.009290
IGFBP3 16 25.2369 TBP 16 30.0017 4.76480 0.036783
IGFBP3 17 25.7785 TBP 17 31.1174 5.33890 0.024708
IGFBP3 18 23.67 TBP 18 29.8854 6.21540 0.013458
0.009059 0.001630
0.0046160.017787
D
IP
D
IP
+
G
H
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Primary MEC from a Jersey cow (Tables 6-10): raw qPCR values corresponding to 
results presented in Figure 5. 
 
 
Appendix Table 6: Q-PCR raw CT values and calculations for -lactalbumin mRNA 
abundance in primary MEC from a Jersey cow cultured for 7 d. 
 
 
Appendix Table 7: Q-PCR raw CT values and calculations for s1-casein mRNA 
abundance in primary MEC from a Jersey cow cultured for 7 d. 
 
 
Appendix Table 8: Q-PCR raw CT values and calculations for GH receptor mRNA 
abundance in primary MEC from a Jersey cow cultured for 7 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
ALAC 1 33.8750 18S 1 12.61380 21.26120 3.978699E-07
ALAC 2 32.4164 18S 2 13.34990 19.06650 1.821426E-06
ALAC 3 33.2099 18S 3 14.32620 18.88370 2.067473E-06
ALAC 4 36.0860 18S 4 12.53010 23.55590 8.109004E-08
ALAC 5 33.6129 18S 5 12.05600 21.55690 3.241354E-07
ALAC 6 33.2850 18S 6 12.95840 20.32660 7.604728E-07
ALAC 7 33.1465 18S 7 13.85050 19.29600 1.553550E-06
ALAC 8 33.2366 18S 8 12.68950 20.54710 6.526894E-07
D
IP
D
IP
+
G
H
1.091965E-06 4.989461E-07
2.606856E-078.227119E-07
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
CAS 1 30.8435 18S 1 12.6138 18.2297 3.253220E-06
CAS 2 30.9295 18S 2 13.3499 17.5796 5.105204E-06
CAS 3 30.2685 18S 3 14.3262 15.9423 1.588143E-05
CAS 4 30.2417 18S 4 12.5301 17.7116 4.658833E-06
CAS 5 29.2374 18S 5 12.056 17.1814 6.727957E-06
CAS 6 29.6532 18S 6 12.9584 16.6948 9.426803E-06
CAS 7 29.0455 18S 7 13.8505 15.195 2.665933E-05
CAS 8 28.8959 18S 8 12.6895 16.2064 1.322475E-05
D
IP
D
IP
+
G
H
7.224671E-06 2.912437E-06
4.422066E-061.400971E-05
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
GHR 1 26.4361 18S 1 12.6138 13.8223 6.903560E-05
GHR 2 27.0933 18S 2 13.3499 13.7434 7.291626E-05
GHR 3 27.8546 18S 3 14.3262 13.5284 8.463418E-05
GHR 4 25.8943 18S 4 12.5301 13.3642 9.483637E-05
GHR 5 25.2033 18S 5 12.056 13.1473 1.102220E-04
GHR 6 25.4063 18S 6 12.9584 12.4479 1.789817E-04
GHR 8 24.5626 18S 8 12.6895 11.8731 2.665881E-04
D
IP
+
G
H
D
IP
8.035560E-05 5.855804E-06
4.524816E-051.852639E-04
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Appendix Table 9: Q-PCR raw CT values and calculations for IGF-I mRNA abundance in 
primary MEC from a Jersey cow cultured for 7 d. 
 
 
Appendix Table 10: Q-PCR raw CT values and calculations for IGFBP-3 mRNA 
abundance in primary MEC from a Jersey cow cultured for 7 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGF-1 1 31.885 18S 1 12.6138 19.2712 1.580486E-06
IGF-1 2 29.8172 18S 2 13.3499 16.4673 1.103694E-05
IGF-1 3 30.392 18S 3 14.3262 16.0658 1.457848E-05
IGF-1 4 31.1653 18S 4 12.5301 18.6352 2.456099E-06
IGF-1 5 30.7174 18S 5 12.056 18.6614 2.411897E-06
IGF-1 6 31.1657 18S 6 12.9584 18.2073 3.304126E-06
IGF-1 7 30.4107 18S 7 13.8505 16.5602 1.034863E-05
IGF-1 8 29.2191 18S 8 12.6895 16.5296 1.057048E-05
D
IP
D
IP
+
G
H
7.413002E-06 3.202423E-06
2.202387E-066.658784E-06
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGFBP3 1 19.6852 18S 1 12.6138 7.0714 0.007435
IGFBP3 2 24.8863 18S 2 13.3499 11.5364 0.000337
IGFBP3 3 22.0761 18S 3 14.3262 7.7499 0.004646
IGFBP3 4 21.3261 18S 4 12.5301 8.796 0.002250
IGFBP3 5 22.4727 18S 5 12.056 10.4167 0.000732
IGFBP3 6 21.1982 18S 6 12.9584 8.2398 0.003308
IGFBP3 7 24.1743 18S 7 13.8505 10.3238 0.000780
IGFBP3 8 24.2517 18S 8 12.6895 11.5622 0.000331
D
IP
D
IP
+
G
H
0.0015350.003667
0.001288 0.000681
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Primary MEC from a Holstein cow (Tables 11-15): raw qPCR values corresponding 
to results presented in Figure 6. 
 
 
Appendix Table 11: Q-PCR raw CT values and calculations for -lactalbumin mRNA 
abundance in primary MEC from a Holstein cow cultured for 7 d. 
 
 
Appendix Table 12: Q-PCR raw CT values and calculations for s1-casein mRNA 
abundance in primary MEC from a Holstein cow cultured for 7 d. 
 
 
Appendix Table 13: Q-PCR raw CT values and calculations for GH receptor mRNA 
abundance in primary MEC from a Holstein cow cultured for 7 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
ALAC 1 35.0438 18S 1 14.0686 20.9752 4.851049E-07
ALAC 2 35.2205 18S 2 13.7097 21.5108 3.346601E-07
ALAC 3 34.9493 18S 3 14.1006 20.8487 5.295609E-07
ALAC 4 35.0254 18S 4 13.7334 21.292 3.894658E-07
ALAC 5 35.4095 18S 5 13.8183 21.5912 3.165200E-07
ALAC 6 34.4291 18S 6 13.5414 20.8877 5.154372E-07
ALAC 7 34.3402 18S 7 13.3279 21.0123 4.727891E-07
4.346979E-07 4.434087E-08
6.046438E-084.349154E-07
D
IP
D
IP
+
G
H
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
CAS 1 37.6757 18S 1 14.0686 23.6071 7.826269E-08
CAS 2 42.9531 18S 2 13.7097 29.2434 1.573473E-09
CAS 3 39.9647 18S 3 14.1006 25.8641 1.637307E-08
CAS 4 38.6556 18S 4 13.7334 24.9222 3.145359E-08
CAS 5 41.7294 18S 5 13.8183 27.9111 3.962066E-09
CAS 6 38.8596 18S 6 13.5414 25.3182 2.390355E-08
CAS 7 41.7331 18S 7 13.3279 28.4052 2.813084E-09
CAS 8 36.3013 18S 8 14.8477 21.4536 3.481953E-07
3.191571E-08 1.660944E-08
8.463085E-089.471850E-08
D
IP
D
IP
+
G
H
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
GHR 1 25.2728 18S 1 14.0686 11.2042 0.000423838
GHR 2 25.6855 18S 2 13.7097 11.9758 0.00024827
GHR 3 25.5869 18S 3 14.1006 11.4863 0.000348561
GHR 4 25.9259 18S 4 13.7334 12.1925 0.000213645
GHR 5 25.7405 18S 5 13.8183 11.9222 0.000257668
GHR 6 25.5746 18S 6 13.5414 12.0332 0.000238586
GHR 7 25.434 18S 7 13.3279 12.1061 0.00022683
GHR 8 25.3235 18S 8 14.8477 10.4758 0.000702215
0.00030858 0.00004790
0.000115470.00035632
D
IP
D
IP
+
G
H
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Appendix Table 14: Q-PCR raw CT values and calculations for IGF-I mRNA abundance 
in primary MEC from a Holstein cow cultured for 7 d. 
 
 
Appendix Table 15: Q-PCR raw CT values and calculations for IGFBP-3 mRNA 
abundance in primary MEC from a Holstein cow cultured for 7 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGF-1 1 28.6594 18S 1 14.0686 14.5908 4.052579E-05
IGF-1 2 27.4961 18S 2 13.7097 13.7864 7.077503E-05
IGF-1 3 27.8476 18S 3 14.1006 13.747 7.273453E-05
IGF-1 4 28.1628 18S 4 13.7334 14.4294 4.532291E-05
IGF-1 5 28.5876 18S 5 13.8183 14.7693 3.580945E-05
IGF-1 6 28.145 18S 6 13.5414 14.6036 4.016783E-05
IGF-1 7 27.4571 18S 7 13.3279 14.1292 5.580678E-05
IGF-1 8 26.6226 18S 8 14.8477 11.7749 2.853658E-04
1.042875E-04
5.733957E-05 8.389575E-06
6.051191E-05
D
IP
D
IP
+
G
H
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGFBP3 1 18.9506 18S 1 14.0686 4.882 0.033913
IGFBP3 2 20.942 18S 2 13.7097 7.2323 0.006651
IGFBP3 3 21.0318 18S 3 14.1006 6.9312 0.008194
IGFBP3 4 20.4311 18S 4 13.7334 6.6977 0.009634
IGFBP3 5 20.4531 18S 5 13.8183 6.6348 0.010063
IGFBP3 6 20.3526 18S 6 13.5414 6.8112 0.008905
IGFBP3 7 20.4487 18S 7 13.3279 7.1208 0.007185
IGFBP3 8 20.8353 18S 8 14.8477 5.9876 0.015760
0.006467
0.0018570.010478
0.014598D
IP
D
IP
+
G
H
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MEC from Holstein milk (Tables 16-20): raw qPCR values corresponding to results 
presented in Figure 7. 
 
 
Appendix Table 16: Q-PCR raw CT values and calculations for -lactalbumin mRNA 
abundance in MEC from Holstein milk cultured for 7 d. 
 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
ALAC 2 39.0751 TBP 2 22.46722422 16.60787578 1.00122E-05
ALAC 3 37.2106 TBP 3 21.57255561 15.63804439 1.96101E-05
ALAC 4 38.0784 TBP 4 21.57362486 16.50477514 1.07539E-05
ALAC 5 37.166 TBP 5 21.75510852 15.41089148 2.29541E-05
ALAC 6 36.6503 TBP 6 22.13608466 14.51421534 4.27352E-05
ALAC 7 37.2433 TBP 7 22.45249931 14.79080069 3.52797E-05
ALAC 8 37.8777 TBP 8 21.6431689 16.2345311 1.29694E-05
ALAC 9 44.9402 TBP 9 21.81917515 23.12102485 1.09617E-07
ALAC 10 37.8668 TBP 10 21.57881884 16.28798116 1.24977E-05
ALAC 11 35.3894 TBP 11 22.06155041 13.32784959 9.72562E-05
ALAC 12 36.2938 TBP 12 22.17592414 14.11787586 5.62466E-05
ALAC 13 36.3021 TBP 13 22.45877618 13.84332382 6.80369E-05
ALAC 14 41.8127 TBP 14 22.0093804 19.8033196 1.09297E-06
ALAC 15 36.1221 TBP 15 22.10227343 14.01982657 6.02021E-05
IN
S
/P
R
O
G
D
IP
D
IP
+
G
H
1.58326E-05 3.22302E-06
7.90292E-062.07183E-05
5.65669E-05 1.56171E-05
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Appendix Table 17: Q-PCR raw CT values and calculations for s1-casein mRNA 
abundance in MEC from Holstein milk cultured for 7 d. 
 
 
Appendix Table 18: Q-PCR raw CT values and calculations for GH receptor mRNA 
abundance in MEC from Holstein milk cultured for 7 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
CAS 1 39.1774 TBP 1 22.47289944 16.70450056 9.36363E-06
CAS 2 39.5444 TBP 2 22.46722422 17.07717578 7.23199E-06
CAS 3 37.4151 TBP 3 21.57255561 15.84254439 1.70184E-05
CAS 4 38.5574 TBP 4 21.57362486 16.98377514 7.71568E-06
CAS 5 37.6491 TBP 5 21.75510852 15.89399148 1.64222E-05
CAS 6 34.2626 TBP 6 22.13608466 12.12651534 0.000223643
CAS 7 34.1528 TBP 7 22.45249931 11.70030069 0.00030051
CAS 8 33.9849 TBP 8 21.6431689 12.3417311 0.00019265
CAS 9 33.3678 TBP 9 21.81917515 11.54862485 0.000333824
CAS 10 33.484 TBP 10 21.57881884 11.90518116 0.000260725
CAS 11 35.5343 TBP 11 22.06155041 13.47274959 8.79626E-05
CAS 12 34.6928 TBP 12 22.17592414 12.51687586 0.000170626
CAS 13 32.4097 TBP 13 22.45877618 9.950923817 0.001010354
CAS 14 32.182 TBP 14 22.0093804 10.1726196 0.000866436
CAS 15 32.4072 TBP 15 22.10227343 10.30492657 0.000790511
IN
S
/P
R
O
G
D
IP
D
IP
+
G
H
1.15504E-05
0.00026227
0.000585178 0.000189884
2.54201E-05
2.14207E-06
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
GHR 1 34.1009 TBP 1 22.47289944 11.62800056 0.000315953
GHR 2 34.0955 TBP 2 22.46722422 11.62827578 0.000315893
GHR 3 33.0429 TBP 3 21.57255561 11.47034439 0.000352438
GHR 4 32.7063 TBP 4 21.57362486 11.13267514 0.00044538
GHR 5 32.5554 TBP 5 21.75510852 10.80029148 0.000560775
GHR 6 31.8345 TBP 6 22.13608466 9.698415344 0.001203611
GHR 7 31.7484 TBP 7 22.45249931 9.295900687 0.001590945
GHR 8 31.413 TBP 8 21.6431689 9.769831095 0.001145481
GHR 9 32.0417 TBP 9 21.81917515 10.22252485 0.000836977
GHR 10 31.303 TBP 10 21.57881884 9.724181157 0.001182306
GHR 11 32.0181 TBP 11 22.06155041 9.956549592 0.001006422
GHR 12 32.7346 TBP 12 22.17592414 10.55867586 0.000663013
GHR 13 31.5495 TBP 13 22.45877618 9.090723817 0.001834085
GHR 14 31.6187 TBP 14 22.0093804 9.609319598 0.001280285
GHR 15 31.987 TBP 15 22.10227343 9.884726569 0.001057793
0.001168319 0.00019359
0.000119915
4.70582E-050.000398088
0.001191864
IN
S
/P
R
O
G
D
IP
D
IP
+
G
H
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Appendix Table 19: Q-PCR raw CT values and calculations for IGF-I mRNA abundance 
in MEC from Holstein milk cultured for 7 d. 
 
 
Appendix Table 20: Q-PCR raw CT values and calculations for IGFBP-3 mRNA 
abundance in MEC from Holstein milk cultured for 7 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGF-1 1 33.3659 TBP 1 22.47289944 10.89300056 0.000525872
IGF-1 2 32.3084 TBP 2 22.46722422 9.841175779 0.001090212
IGF-1 3 31.7706 TBP 3 21.57255561 10.19804439 0.0008513
IGF-1 4 35.544 TBP 4 21.57362486 13.97037514 6.23014E-05
IGF-1 5 35.1754 TBP 5 21.75510852 13.42029148 9.12199E-05
IGF-1 6 33.5583 TBP 6 22.13608466 11.42221534 0.000364393
IGF-1 7 32.6163 TBP 7 22.45249931 10.16380069 0.000871748
IGF-1 8 32.8773 TBP 8 21.6431689 11.2341311 0.000415135
IGF-1 9 35.1887 TBP 9 21.81917515 13.36952485 9.4487E-05
IGF-1 10 35.1275 TBP 10 21.57881884 13.54868116 8.34527E-05
IGF-1 11 32.9106 TBP 11 22.06155041 10.84904959 0.000542139
IGF-1 12 32.9823 TBP 12 22.17592414 10.80637586 0.000558415
IGF-1 13 29.5131 TBP 13 22.45877618 7.054323817 0.007523795
IGF-1 14 34.3348 TBP 14 22.0093804 12.3254196 0.00019484
IGF-1 15 33.4478 TBP 15 22.10227343 11.34552657 0.000384287
0.0014222880.001840695
IN
S
/P
R
O
G
D
IP
D
IP
+
G
H
0.0002034930.000524181
0.000365843 0.000143484
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGFBP3 1 22.1111 TBP 1 22.47289944 0.361799438 0.778193353
IGFBP3 2 21.69 TBP 2 22.46722422 0.777224221 0.583488359
IGFBP3 3 22.918 TBP 3 21.57255561 1.345444386 0.393532752
IGFBP3 4 22.6583 TBP 4 21.57362486 1.084675143 0.471498425
IGFBP3 5 23.5202 TBP 5 21.75510852 1.765091477 0.294208029
IGFBP3 6 21.8865 TBP 6 22.13608466 0.249584656 0.84113854
IGFBP3 7 21.7177 TBP 7 22.45249931 0.734799313 0.600901608
IGFBP3 8 22.4257 TBP 8 21.6431689 0.782531095 0.581345972
IGFBP3 9 22.9201 TBP 9 21.81917515 1.100924846 0.466217529
IGFBP3 10 22.9709 TBP 10 21.57881884 1.392081157 0.381014773
IGFBP3 11 20.9935 TBP 11 22.06155041 1.068050408 0.47696311
IGFBP3 12 21.4078 TBP 12 22.17592414 0.768124137 0.587180459
IGFBP3 13 22.7068 TBP 13 22.45877618 0.248023817 0.842049053
IGFBP3 14 22.7416 TBP 14 22.0093804 0.732219598 0.601977055
IGFBP3 15 23.4552 TBP 15 22.10227343 1.352926569 0.391497074
0.083298338
0.077782049
0.0759454370.57993335
0.574123684
0.504184184
IN
S
/P
R
O
G
D
IP
D
IP
+
G
H
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Primary MEC from a Holstein cow (Table 21-25): raw qPCR values corresponding 
to results presented in Figure 8. 
 
 
Appendix Table 21: Q-PCR raw CT values and calculations for -lactalbumin mRNA 
abundance in primary MEC from a Holstein cow cultured for 2 d and 4 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
ALAC 1 37.8121 POL1 1 22.1496 15.6625 1.92805E-05
ALAC 2 35.0814 POL1 2 21.5752 13.5062 8.59466E-05
ALAC 3 35.3206 POL1 3 22.111 13.2096 0.000105564
ALAC 4 35.3557 POL1 4 22.0638 13.2919 9.97102E-05
ALAC 5 34.3295 POL1 5 22.044 12.2855 0.000200307
ALAC 6 35.0221 POL1 6 22.7134 12.3087 0.000197112
ALAC 7 35.0082 POL1 7 21.4217 13.5865 8.12935E-05
ALAC 8 35.7172 POL1 8 23.8427 11.8745 0.00026633
ALAC 9 32.1319 POL1 9 22.0195 10.1124 0.000903367
ALAC 10 32.9837 POL1 10 22.1765 10.8072 0.000558096
ALAC 11 33.9591 POL1 11 24.0026 9.9565 0.001006456
ALAC 12 35.1085 POL1 12 22.4189 12.6896 0.000151373
ALAC 13 37.0585 POL1 13 21.7222 15.3363 2.41721E-05
ALAC 14 35.8989 POL1 14 21.9122 13.9867 6.16004E-05
ALAC 15 35.1477 POL1 15 22.6009 12.5468 0.000167123
ALAC 16 34.6513 POL1 16 22.3455 12.3058 0.000197508
ALAC 17 34.0734 POL1 17 22.1725 11.9009 0.0002615
ALAC 18 34.4364 POL1 18 21.9373 12.4991 0.000172741
ALAC 19 34.1859 POL1 19 22.6033 11.5826 0.000326054
ALAC 20 35.2209 POL1 20 22.8117 12.4092 0.000183848
ALAC 21 35.1489 POL1 21 22.7896 12.3593 0.000190318
ALAC 22 34.0872 POL1 22 21.7237 12.3635 0.000189765
ALAC 23 35.7661 POL1 23 21.9127 13.8534 6.75633E-05
ALAC 24 35.3991 POL1 24 22.0464 13.3527 9.55954E-05
ALAC 25 34.3812 POL1 25 24.1931 10.1881 0.000857188
0.000146367
0.000102162 2.89675E-05
0.000148150.000401239
0.000282145 0.00018305
2
 D
A
Y
S
4
 D
A
Y
S
IN
S
/P
R
O
G
D
IP
D
IP
+
G
H
D
IP
D
IP
+
G
H
3.22772E-050.00022833
0.000280086
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Appendix Table 22: Q-PCR raw CT values and calculations for s1-casein mRNA 
abundance in primary MEC from a Holstein cow cultured for 2 d and 4 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
CAS 1 38.554 POL1 1 22.1496 16.4044 1.15288E-05
CAS 2 40.8805 POL1 2 21.5752 19.3053 1.54357E-06
CAS 3 39.1396 POL1 3 22.111 17.0286 7.47964E-06
CAS 4 38.6832 POL1 4 22.0638 16.6194 9.93258E-06
CAS 5 40.4514 POL1 5 22.044 18.4074 2.87621E-06
CAS 6 43.3289 POL1 6 22.7134 20.6155 6.22467E-07
CAS 7 40.0032 POL1 7 21.4217 18.5815 2.54924E-06
CAS 8 40.9918 POL1 8 23.8427 17.1491 6.88029E-06
CAS 9 37.5321 POL1 9 22.0195 15.5126 2.13915E-05
CAS 11 47.2617 POL1 11 24.0026 23.2591 9.96124E-08
CAS 12 37.957 POL1 12 22.4189 15.5381 2.10168E-05
CAS 13 41.6762 POL1 13 21.7222 19.954 9.84572E-07
CAS 14 38.4875 POL1 14 21.9122 16.5753 1.02409E-05
CAS 15 43.1023 POL1 15 22.6009 20.5014 6.73696E-07
CAS 16 36.9696 POL1 16 22.3455 14.6241 3.96011E-05
CAS 17 45.906 POL1 17 22.1725 23.7335 7.16976E-08
CAS 18 42.227 POL1 18 21.9373 20.2897 7.80174E-07
CAS 19 39.838 POL1 19 22.6033 17.2347 6.48393E-06
CAS 20 39.1629 POL1 20 22.8117 16.3512 1.19618E-05
CAS 21 44.7949 POL1 21 22.7896 22.0053 2.37544E-07
CAS 22 36.6001 POL1 22 21.7237 14.8764 3.32474E-05
CAS 24 48.2958 POL1 24 22.0464 26.2494 1.25355E-08
CAS 25 40.4586 POL1 25 24.1931 16.2655 1.26939E-05
7.81649E-061.15479E-05
1.94398E-06
4.69617E-06
4.06207E-066.60311E-06
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Appendix Table 23: Q-PCR raw CT values and calculations for GH receptor mRNA 
abundance in primary MEC from a Holstein cow cultured for 2 d and 4 d. 
 
GHR 1 25.4279 POL1 1 22.1496 3.2783 0.103070258
GHR 2 24.8639 POL1 2 21.5752 3.2887 0.102329924
GHR 3 23.7643 POL1 3 22.111 1.6533 0.317912137
GHR 4 23.8747 POL1 4 22.0638 1.8109 0.285013073
GHR 5 24.3055 POL1 5 22.044 2.2615 0.208555028
GHR 6 23.3232 POL1 6 22.7134 0.6098 0.655287538
GHR 7 24.5285 POL1 7 21.4217 3.1068 0.116080698
GHR 8 23.3098 POL1 8 23.8427 0.5329 0.691164009
GHR 9 25.6134 POL1 9 22.0195 3.5939 0.082818679
GHR 10 26.3277 POL1 10 22.1765 4.1512 0.056281321
GHR 11 23.9434 POL1 11 24.0026 0.0592 0.959796196
GHR 12 24.5908 POL1 12 22.4189 2.1719 0.221918216
GHR 13 24.4729 POL1 13 21.7222 2.7507 0.148578781
GHR 14 24.7311 POL1 14 21.9122 2.8189 0.141718499
GHR 15 24.0039 POL1 15 22.6009 1.403 0.378141999
GHR 16 24.1323 POL1 16 22.3455 1.7868 0.289814162
GHR 17 23.5285 POL1 17 22.1725 1.356 0.39066394
GHR 18 23.268 POL1 18 21.9373 1.3307 0.39757529
GHR 19 24.1414 POL1 19 22.6033 1.5381 0.344338643
GHR 20 24.0996 POL1 20 22.8117 1.2879 0.409546736
GHR 21 24.2947 POL1 21 22.7896 1.5051 0.352305768
GHR 22 24.0402 POL1 22 21.7237 2.3165 0.200753911
GHR 23 23.9745 POL1 23 21.9127 2.0618 0.239517006
GHR 24 24.0312 POL1 24 22.0464 1.9848 0.252647884
GHR 25 24.0879 POL1 25 24.1931 0.1052 0.929676053
0.203376084 0.044766903
0.320326449 0.14449317
0.153459091
0.024716355
0.1359911590.394980124
0.366387754
0.370030738
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Appendix Table 24: Q-PCR raw CT values and calculations for IGF-I mRNA abundance 
in primary MEC from a Holstein cow cultured for 2 d and 4d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGF1 1 30.859 POL1 1 22.1496 8.7094 0.002388963
IGF1 2 30.916 POL1 2 21.5752 9.3408 0.001542194
IGF1 3 30.5103 POL1 3 22.111 8.3993 0.002961821
IGF1 4 30.4938 POL1 4 22.0638 8.43 0.00289946
IGF1 6 31.3717 POL1 6 22.7134 8.6583 0.002475096
IGF1 7 29.9586 POL1 7 21.4217 8.5369 0.002692384
IGF1 8 31.169 POL1 8 23.8427 7.3263 0.006231089
IGF1 9 30.0339 POL1 9 22.0195 8.0144 0.003867454
IGF1 11 31.3547 POL1 11 24.0026 7.3521 0.006120648
IGF1 12 31.9041 POL1 12 22.4189 9.4852 0.001395309
IGF1 13 31.3803 POL1 13 21.7222 9.6581 0.001237719
IGF1 14 31.7548 POL1 14 21.9122 9.8426 0.001089136
IGF1 15 31.1654 POL1 15 22.6009 8.5645 0.002641366
IGF1 16 31.3141 POL1 16 22.3455 8.9686 0.0019961
IGF1 17 30.7546 POL1 17 22.1725 8.5821 0.002609339
IGF1 18 30.3076 POL1 18 21.9373 8.3703 0.003021959
IGF1 19 30.0295 POL1 19 22.6033 7.4262 0.005814214
IGF1 20 30.6657 POL1 20 22.8117 7.854 0.004322255
IGF1 21 30.6987 POL1 21 22.7896 7.9091 0.004160291
IGF1 22 29.9946 POL1 22 21.7237 8.2709 0.003237509
IGF1 23 31.4874 POL1 23 21.9127 9.5747 0.001311379
IGF1 24 31.6112 POL1 24 22.0464 9.5648 0.001320408
IGF1 25 31.711 POL1 25 24.1931 7.5179 0.005456154
0.000762450.003552774
0.003097148 0.000808104
0.002448109 0.0003281
0.00121740.003799523
0.002496836 0.000946923
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Appendix Table 25: Q-PCR raw CT values and calculations for IGFBP-3 mRNA 
abundance in primary MEC from a Holstein cow cultured for 2 d and 4 d. 
 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGFBP3 1 25.2027 POL1 1 22.1496 3.0531 0.120482874
IGFBP3 2 25.1948 POL1 2 21.5752 3.6196 0.08135642
IGFBP3 3 26.1638 POL1 3 22.111 4.0528 0.060253965
IGFBP3 4 25.8117 POL1 4 22.0638 3.7479 0.074433712
IGFBP3 5 25.4179 POL1 5 22.044 3.3739 0.096461697
IGFBP3 6 25.8435 POL1 6 22.7134 3.1301 0.114221014
IGFBP3 7 23.1833 POL1 7 21.4217 1.7616 0.294920906
IGFBP3 8 23.8917 POL1 8 23.8427 0.049 0.966606097
IGFBP3 9 20.2331 POL1 9 22.0195 -1.7864 0.289894527
IGFBP3 10 19.4783 POL1 10 22.1765 -2.6982 0.154085178
IGFBP3 11 26.7944 POL1 11 24.0026 2.7918 0.144405741
IGFBP3 12 24.457 POL1 12 22.4189 2.0381 0.24348419
IGFBP3 13 25.7321 POL1 13 21.7222 4.0099 0.062072583
IGFBP3 14 25.719 POL1 14 21.9122 3.8068 0.071456051
IGFBP3 15 25.344 POL1 15 22.6009 2.7431 0.149363547
IGFBP3 16 22.8383 POL1 16 22.3455 0.4928 0.710644531
IGFBP3 17 24.6386 POL1 17 22.1725 2.4661 0.180979727
IGFBP3 18 23.9245 POL1 18 21.9373 1.9872 0.25222794
IGFBP3 19 22.127 POL1 19 22.6033 -0.4763 0.718818777
IGFBP3 20 23.8673 POL1 20 22.8117 1.0556 0.481097097
IGFBP3 21 24.4714 POL1 21 22.7896 1.6818 0.311693505
IGFBP3 22 24.2606 POL1 22 21.7237 2.5369 0.172312588
IGFBP3 23 24.1365 POL1 23 21.9127 2.2238 0.214076746
IGFBP3 24 24.9774 POL1 24 22.0464 2.931 0.131123666
IGFBP3 25 26.385 POL1 25 24.1931 2.1919 0.218863002
0.1252231360.468753614
0.209613902 0.030064775
0.01028331
0.1548953530.363945544
0.134156422 0.032723296
0.086597734
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Primary MEC from a Jersey cow (Table 26-30): raw qPCR values corresponding to 
results presented in Figure 9. 
 
 
Appendix Table 26: Q-PCR raw CT values and calculations for -lactalbumin mRNA 
abundance in primary MEC from a Jersey cow cultured for 2 d and 4 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
ALAC 1 34.5856 POL1 1 21.6008 12.9848 0.000123363
ALAC 2 32.9151 POL1 2 21.5417 11.3734 0.000376934
ALAC 3 33.8853 POL1 3 22.12 11.7653 0.000287271
ALAC 4 33.5719 POL1 4 21.0434 12.5285 0.000169257
ALAC 5 34.8125 POL1 5 21.5339 13.2786 0.000100634
ALAC 6 33.3643 POL1 6 21.7818 11.5825 0.000326077
ALAC 7 33.937 POL1 7 21.8675 12.0695 0.000232658
ALAC 8 35.666 POL1 8 22.0168 13.6492 7.78362E-05
ALAC 9 33.1407 POL1 9 21.393 11.7477 0.000290797
ALAC 10 34.791 POL1 10 21.2424 13.5486 8.34574E-05
ALAC 11 33.9952 POL1 11 21.1259 12.8693 0.000133646
ALAC 12 33.5492 POL1 12 21.7264 11.8228 0.000276047
ALAC 13 33.1541 POL1 13 21.7135 11.4406 0.000359779
ALAC 14 33.7221 POL1 14 22.3513 11.3708 0.000377614
ALAC 15 34.6979 POL1 15 21.9469 12.751 0.000145066
ALAC 16 33.9162 POL1 16 22.3855 11.5307 0.000337997
ALAC 17 33.122 POL1 17 21.9234 11.1986 0.000425486
ALAC 18 34.9406 POL1 18 21.2639 13.6767 7.63665E-05
ALAC 19 34.3869 POL1 19 21.1321 13.2548 0.000102308
ALAC 20 34.0648 POL1 20 21.7294 12.3354 0.000193497
ALAC 21 32.9287 POL1 21 22.1445 10.7842 0.000567064
ALAC 22 34.0601 POL1 22 20.822 13.2381 0.000103499
ALAC 23 34.6318 POL1 23 21.1386 13.4932 8.67246E-05
ALAC 24 34.3308 POL1 24 22.0556 12.2752 0.000201742
ALAC 25 34.0154 POL1 25 21.848 12.1674 0.000217394
7.54479E-050.000227131
0.000235285 8.68794E-05
0.000211492 5.24183E-05
5.18116E-050.000202165
0.00025843 5.15797E-05
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Appendix Table 27: Q-PCR raw CT values and calculations for s1-casein mRNA 
abundance in primary MEC from a Jersey cow cultured for 2 d and 4 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
CAS 1 31.4597 POL1 1 21.6008 9.8589 0.0010769
CAS 2 32.0113 POL1 2 21.5417 10.4696 0.000705239
CAS 3 32.6377 POL1 3 22.12 10.5177 0.000682114
CAS 4 31.8314 POL1 4 21.0434 10.788 0.000565573
CAS 5 30.3237 POL1 5 21.5339 8.7898 0.00225947
CAS 6 30.8572 POL1 6 21.7818 9.0754 0.00185367
CAS 7 30.1443 POL1 7 21.8675 8.2768 0.003224296
CAS 8 32.8435 POL1 8 22.0168 10.8267 0.000550603
CAS 9 29.8539 POL1 9 21.393 8.4609 0.002838019
CAS 10 29.8653 POL1 10 21.2424 8.6229 0.002536579
CAS 11 29.9966 POL1 11 21.1259 8.8707 0.002136256
CAS 12 31.3127 POL1 12 21.7264 9.5863 0.001300877
CAS 13 29.7951 POL1 13 21.7135 8.0816 0.003691441
CAS 14 30.5838 POL1 14 22.3513 8.2325 0.003324839
CAS 15 31.5892 POL1 15 21.9469 9.6423 0.001251349
CAS 16 31.2776 POL1 16 22.3855 8.8921 0.002104802
CAS 17 31.8075 POL1 17 21.9234 9.8841 0.001058253
CAS 18 32.9138 POL1 18 21.2639 11.6499 0.000311194
CAS 20 30.7511 POL1 20 21.7294 9.0217 0.001923967
CAS 21 29.1547 POL1 21 22.1445 7.0102 0.00775746
CAS 22 31.4587 POL1 22 20.822 10.6367 0.000628108
CAS 23 32.4016 POL1 23 21.1386 11.263 0.000406911
CAS 24 31.4536 POL1 24 22.0556 9.398 0.001482245
0.0004146680.001349554
0.002568681 0.001745061
0.001057859 0.000312418
0.0004695740.002200633
0.002340952 0.000505111
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Appendix Table 28: Q-PCR raw CT values and calculations for GH receptor mRNA 
abundance in primary MEC from a Jersey cow cultured for 2 d and 4 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
GHR 1 25.4218 POL1 1 21.6008 3.821 0.070756181
GHR 2 26.0969 POL1 2 21.5417 4.5552 0.042535169
GHR 3 26.4875 POL1 3 22.12 4.3675 0.048445283
GHR 4 25.2684 POL1 4 21.0434 4.225 0.053474689
GHR 5 26.0717 POL1 5 21.5339 4.5378 0.043051282
GHR 6 25.4046 POL1 6 21.7818 3.6228 0.081176165
GHR 7 25.0794 POL1 7 21.8675 3.2119 0.107924925
GHR 8 25.8172 POL1 8 22.0168 3.8004 0.071773745
GHR 9 25.4984 POL1 9 21.393 4.1054 0.058096699
GHR 10 25.7299 POL1 10 21.2424 4.4875 0.044578751
GHR 11 24.733 POL1 11 21.1259 3.6071 0.082064382
GHR 12 24.6731 POL1 12 21.7264 2.9467 0.129704461
GHR 13 24.1415 POL1 13 21.7135 2.428 0.185822873
GHR 14 24.0396 POL1 14 22.3513 1.6883 0.310292343
GHR 15 23.9413 POL1 15 21.9469 1.9944 0.250972292
GHR 16 25.1113 POL1 16 22.3855 2.7258 0.151165414
GHR 17 25.0513 POL1 17 21.9234 3.1279 0.114395325
GHR 18 25.2565 POL1 18 21.2639 3.9926 0.062821404
GHR 19 25.3844 POL1 19 21.1321 4.2523 0.052472306
GHR 20 26.8547 POL1 20 21.7294 5.1253 0.028650418
GHR 21 24.3259 POL1 21 22.1445 2.1814 0.220461708
GHR 22 24.7417 POL1 22 20.822 3.9197 0.066077367
GHR 23 25.3985 POL1 23 21.1386 4.2599 0.052196613
GHR 24 25.8792 POL1 24 22.0556 3.8236 0.070628781
GHR 25 25.3945 POL1 25 21.848 3.5465 0.085584895
0.081900973 0.024898724
0.0368276190.098989872
0.0051752480.051652521
0.072710057 0.010764663
0.040911660.19177127
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Appendix Table 29: Q-PCR raw CT values and calculations for IGF-I mRNA abundance 
in primary MEC from a Jersey cow cultured for 2 d and 4d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGF1 1 29.6025 POL1 1 21.6008 8.0017 0.00390165
IGF1 2 29.6337 POL1 2 21.5417 8.092 0.003664927
IGF1 3 29.6476 POL1 3 22.12 7.5276 0.005419592
IGF1 4 29.7737 POL1 4 21.0434 8.7303 0.002354604
IGF1 5 30.0647 POL1 5 21.5339 8.5308 0.002703792
IGF1 6 31.3099 POL1 6 21.7818 9.5281 0.001354429
IGF1 7 30.1355 POL1 7 21.8675 8.268 0.003244024
IGF1 8 33.2513 POL1 8 22.0168 11.2345 0.000415029
IGF1 9 30.1739 POL1 9 21.393 8.7809 0.002273452
IGF1 10 31.7437 POL1 10 21.2424 10.5013 0.000689912
IGF1 11 29.8128 POL1 11 21.1259 8.6869 0.002426512
IGF1 12 30.6218 POL1 12 21.7264 8.8954 0.002099993
IGF1 13 31.35 POL1 13 21.7135 9.6365 0.00125639
IGF1 14 30.933 POL1 14 22.3513 8.5817 0.002610062
IGF1 15 34.3195 POL1 15 21.9469 12.3726 0.000188572
IGF1 16 32.9366 POL1 16 22.3855 10.5511 0.000666503
IGF1 17 30.4395 POL1 17 21.9234 8.5161 0.002731483
IGF1 18 32.1584 POL1 18 21.2639 10.8945 0.000525326
IGF1 19 32.5702 POL1 19 21.1321 11.4381 0.000360403
IGF1 20 32.2546 POL1 20 21.7294 10.5252 0.000678577
IGF1 22 31.9508 POL1 22 20.822 11.1288 0.000446578
IGF1 23 31.271 POL1 23 21.1386 10.1324 0.00089093
IGF1 24 30.573 POL1 24 22.0556 8.5174 0.002729022
IGF1 25 29.9926 POL1 25 21.848 8.1446 0.003533712
0.003608913
0.001595369
0.001716306
0.000992458
0.001900061 0.000735241
0.000490324
0.000446985
0.000521966
0.000536653
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Appendix Table 30: Q-PCR raw CT values and calculations for IGFBP-3 mRNA 
abundance in primary MEC from a Jersey cow cultured for 2 d and 4 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGFBP3 1 26.3767 POL1 1 21.6008 4.7759 0.036501511
IGFBP3 2 26.4466 POL1 2 21.5417 4.9049 0.033379358
IGFBP3 3 26.7508 POL1 3 22.12 4.6308 0.040363637
IGFBP3 4 25.5961 POL1 4 21.0434 4.5527 0.042608941
IGFBP3 5 26.2400 POL1 5 21.5339 4.7061 0.038310934
IGFBP3 6 26.3926 POL1 6 21.7818 4.6108 0.040927093
IGFBP3 7 27.4488 POL1 7 21.8675 5.5813 0.020886289
IGFBP3 8 25.6509 POL1 8 22.0168 3.6341 0.080542831
IGFBP3 10 26.6064 POL1 10 21.2424 5.364 0.024281477
IGFBP3 11 29.3348 POL1 11 21.1259 8.2089 0.003379674
IGFBP3 12 26.0112 POL1 12 21.7264 4.2848 0.051303462
IGFBP3 13 24.9722 POL1 13 21.7135 3.2587 0.104480094
IGFBP3 14 27.7126 POL1 14 22.3513 5.3613 0.024326962
IGFBP3 15 25.9847 POL1 15 21.9469 4.0378 0.060883706
IGFBP3 17 26.6946 POL1 17 21.9234 4.7712 0.036620619
IGFBP3 18 23.8805 POL1 18 21.2639 2.6166 0.163051543
IGFBP3 19 23.2112 POL1 19 21.1321 2.0791 0.236662003
IGFBP3 20 25.6465 POL1 20 21.7294 3.9171 0.066196557
IGFBP3 21 25.9182 POL1 21 22.1445 3.7737 0.073114431
IGFBP3 22 23.1279 POL1 22 20.822 2.3059 0.202234354
IGFBP3 23 24.4609 POL1 23 21.1386 3.3223 0.099974225
IGFBP3 24 24.9623 POL1 24 22.0556 2.9067 0.133350949
0.039140462
0.041659423
0.04887478
0.125632681
0.12510767 0.052712988
0.045810735
0.017196604
0.013680801
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MEC from Holstein milk (Tables 31-35): raw qPCR values corresponding to results 
presented in Figure 10. 
 
 
Appendix Table 31: Q-PCR raw CT values and calculations for -lactalbumin mRNA 
abundance in MEC from Holstein milk cultured for 2 d and 4 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
ALAC 1 35.4827 18S 1 11.4193 24.0634 5.7042E-08
ALAC 2 35.3123 18S 2 11.9428 23.3695 9.2274E-08
ALAC 3 35.059 18S 3 11.2765 23.7825 6.93033E-08
ALAC 4 34.6648 18S 4 11.5985 23.0663 1.13855E-07
ALAC 5 34.7661 18S 5 11.7494 23.0167 1.17837E-07
ALAC 6 34.0765 18S 6 11.054 23.0225 1.17365E-07
ALAC 7 34.8795 18S 7 12.7561 22.1234 2.18873E-07
ALAC 8 34.0782 18S 8 11.5817 22.4965 1.68997E-07
ALAC 9 33.3754 18S 9 11.1304 22.245 2.01181E-07
ALAC 10 35.7723 18S 10 11.9081 23.8642 6.54877E-08
ALAC 11 35.7088 18S 11 11.2243 24.4845 4.26021E-08
ALAC 12 34.0201 18S 12 11.7701 22.25 2.00485E-07
ALAC 13 34.7988 18S 13 11.7107 23.0881 1.12147E-07
ALAC 14 35.1879 18S 14 11.105 24.0829 5.62762E-08
ALAC 15 34.6257 18S 15 11.9876 22.6381 1.53198E-07
4.92585E-081.02858E-07
1.07207E-07 2.80877E-08
7.28731E-08 1.0326E-08
1.9912E-091.15846E-07
1.93935E-07 2.49383E-08
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Appendix Table 32: Q-PCR raw CT values and calculations for s1-casein mRNA 
abundance in MEC from Holstein milk cultured for 2 d and 4 d. 
 
 
Appendix Table 33: Q-PCR raw CT values and calculations for GH receptor mRNA 
abundance in MEC from Holstein milk cultured for 2 d and 4 d. 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
CAS 1 27.2279 18S 1 11.4193 15.8086 1.74236E-05
CAS 2 27.1989 18S 2 11.9428 15.2561 2.55538E-05
CAS 3 27.5104 18S 3 11.2765 16.2339 1.29751E-05
CAS 4 25.5287 18S 4 11.5985 13.9302 6.40607E-05
CAS 5 27.7938 18S 5 11.7494 16.0444 1.47963E-05
CAS 6 25.7238 18S 6 11.054 14.6698 3.83663E-05
CAS 7 26.2087 18S 7 12.7561 13.4526 8.91998E-05
CAS 8 25.6664 18S 8 11.5817 14.0847 5.7555E-05
CAS 9 25.9651 18S 9 11.1304 14.8347 3.42224E-05
CAS 10 26.1668 18S 10 11.9081 14.2587 5.10157E-05
CAS 11 26.9529 18S 11 11.2243 15.7286 1.8417E-05
CAS 12 26.252 18S 12 11.7701 14.4819 4.37032E-05
CAS 13 26.8458 18S 13 11.7107 15.1351 2.77895E-05
CAS 14 27.1406 18S 14 11.105 16.0356 1.48869E-05
CAS 15 26.2786 18S 15 11.9876 14.291 4.98862E-05
9.87572E-063.7712E-05
3.08542E-05 1.0219E-05
1.86508E-05 3.68267E-06
1.42258E-053.90745E-05
6.03257E-05 1.5931E-05
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TX Sample ID CT HKG ID CT CT 2-CT Average SEM
GHR 1 29.8442 18S 1 11.4193 18.4249 2.84153E-06
GHR 2 29.9773 18S 2 11.9428 18.0345 3.72456E-06
GHR 3 29.3031 18S 3 11.2765 18.0266 3.74501E-06
GHR 4 29.6643 18S 4 11.5985 18.0658 3.64462E-06
GHR 5 29.8924 18S 5 11.7494 18.143 3.45472E-06
GHR 6 29.7271 18S 6 11.054 18.6731 2.39242E-06
GHR 7 30.1897 18S 7 12.7561 17.4336 5.64889E-06
GHR 8 29.7598 18S 8 11.5817 18.1781 3.37168E-06
GHR 9 30.0543 18S 9 11.1304 18.9239 2.01066E-06
GHR 10 29.1504 18S 10 11.9081 17.2423 6.44986E-06
GHR 11 29.348 18S 11 11.2243 18.1237 3.50125E-06
GHR 12 29.0614 18S 12 11.7701 17.2913 6.23448E-06
GHR 13 28.8586 18S 13 11.7107 17.1479 6.88601E-06
GHR 14 29.6955 18S 14 11.105 18.5905 2.53339E-06
GHR 15 29.4214 18S 15 11.9876 17.4338 5.64811E-06
1.29484E-06
9.49014E-07
1.06131E-06
3.89627E-07
2.97809E-073.43703E-06
3.16392E-06
3.67708E-06
5.3952E-06
5.0225E-06
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Appendix Table 34: Q-PCR raw CT values and calculations for IGF-I mRNA abundance 
in MEC from Holstein milk cultured for 2 d and 4 d. 
 
 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGF1 1 29.1346 18S 1 11.4193 17.7153 4.6469E-06
IGF1 2 29.9543 18S 2 11.9428 18.0115 3.78441E-06
IGF1 3 30.1364 18S 3 11.2765 18.8599 2.10186E-06
IGF1 4 29.814 18S 4 11.5985 18.2155 3.2854E-06
IGF1 5 32.0904 18S 5 11.7494 20.341 7.5292E-07
IGF1 6 30.4109 18S 6 11.054 19.3569 1.48934E-06
IGF1 7 30.8813 18S 7 12.7561 18.1252 3.49761E-06
IGF1 8 30.9606 18S 8 11.5817 19.3789 1.4668E-06
IGF1 9 30.8454 18S 9 11.1304 19.715 1.16197E-06
IGF1 10 30.1747 18S 10 11.9081 18.2666 3.17107E-06
IGF1 11 30.7431 18S 11 11.2243 19.5188 1.33124E-06
IGF1 12 30.8705 18S 12 11.7701 19.1004 1.77913E-06
IGF1 13 30.5918 18S 13 11.7107 18.8811 2.0712E-06
IGF1 14 30.9002 18S 14 11.105 19.7952 1.09913E-06
IGF1 15 31.4391 18S 15 11.9876 19.4515 1.39481E-06
2.87696E-07
5.53929E-07
7.33043E-07
7.52093E-07
7.47294E-073.51106E-06
1.84255E-06
2.04212E-06
2.09381E-06
1.52172E-06
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Appendix Table 35: Q-PCR raw CT values and calculations for IGFBP-3 mRNA 
abundance in MEC from Holstein milk cultured for 2 d and 4 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGFBP3 1 22.914 18S 1 11.4193 11.4947 0.000346538
IGFBP3 2 22.3074 18S 2 11.9428 10.3646 0.000758481
IGFBP3 3 22.609 18S 3 11.2765 11.3325 0.000387773
IGFBP3 4 21.2056 18S 4 11.5985 9.6071 0.001282256
IGFBP3 5 21.4797 18S 5 11.7494 9.7303 0.001177302
IGFBP3 6 21.1783 18S 6 11.054 10.1243 0.000895946
IGFBP3 7 22.1124 18S 7 12.7561 9.3563 0.001525714
IGFBP3 8 22.5555 18S 8 11.5817 10.9738 0.00049723
IGFBP3 9 22.4912 18S 9 11.1304 11.3608 0.000380241
IGFBP3 10 20.057 18S 10 11.9081 8.1489 0.003523195
IGFBP3 11 19.7262 18S 11 11.2243 8.5019 0.002758501
IGFBP3 12 20.0162 18S 12 11.7701 8.2461 0.003293643
IGFBP3 13 20.3635 18S 13 11.7107 8.6528 0.002484549
IGFBP3 14 20.4964 18S 14 11.105 9.3914 0.001489042
IGFBP3 15 20.9867 18S 15 11.9876 8.9991 0.001954344
0.000497754
0.000226548
0.000363897
0.000115328
0.0001309840.000497597
0.001118501
0.000801061
0.00319178
0.001986796
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MEC from Jersey milk (Tables 36-40): raw qPCR values corresponding to results 
presented in Figure 11. 
 
 
Appendix Table 36: Q-PCR raw CT values and calculations for -lactalbumin mRNA 
abundance in MEC from Jersey milk cultured for 2 d and 4 d. 
 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
ALAC 1 36.9548 ACTB 1 17.3359 19.6189 1.24200E-06
ALAC 2 36.2916 ACTB 2 17.7941 18.4975 2.70208E-06
ALAC 3 36.4954 ACTB 3 16.5536 19.9418 9.92933E-07
ALAC 4 33.4253 ACTB 4 17.2348 16.1905 1.33713E-05
ALAC 5 34.2052 ACTB 5 16.7007 17.5045 5.37800E-06
ALAC 6 34.2396 ACTB 6 16.3691 17.8705 4.17295E-06
ALAC 7 35.6313 ACTB 7 16.2588 19.3725 1.47332E-06
ALAC 8 34.4467 ACTB 8 17.8703 16.5764 1.02331E-05
ALAC 9 34.1958 ACTB 9 16.6322 17.5636 5.16214E-06
ALAC 10 35.7032 ACTB 10 17.827 17.8762 4.15650E-06
ALAC 11 33.7961 ACTB 11 17.1318 16.6643 9.62822E-06
ALAC 12 35.3421 ACTB 12 16.3276 19.0145 1.88827E-06
ALAC 13 34.0834 ACTB 13 16.5664 17.517 5.33160E-06
ALAC 14 35.4741 ACTB 14 17.9596 17.5145 5.34085E-06
ALAC 15 34.5708 ACTB 15 17.2943 17.2765 6.29876E-06
5.22433E-06
5.65707E-06 3.20858E-07
2.29724E-06
1.64567E-06 5.33074E-07
2.88632E-06
2.53920E-065.62285E-06
7.64075E-06
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Appendix Table 37: Q-PCR raw CT values and calculations for s1-casein mRNA 
abundance in MEC from Jersey milk cultured for 2 d and 4 d. 
 
 
Appendix Table 38: Q-PCR raw CT values and calculations for GH receptor mRNA 
abundance in MEC from Jersey milk cultured for 2 d and 4 d. 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
CAS 1 29.3246 ACTB 1 17.3359 11.9887 0.0002461
CAS 2 29.2735 ACTB 2 17.7941 11.4794 0.0003502
CAS 3 28.758 ACTB 3 16.5536 12.2044 0.0002119
CAS 4 27.5161 ACTB 4 17.2348 10.2813 0.0008036
CAS 5 26.6418 ACTB 5 16.7007 9.9411 0.0010173
CAS 6 26.4829 ACTB 6 16.3691 10.1138 0.0009025
CAS 7 27.4095 ACTB 7 16.2588 11.1507 0.0004399
CAS 8 27.0591 ACTB 8 17.8703 9.1888 0.0017135
CAS 9 26.0651 ACTB 9 16.6322 9.4329 0.0014468
CAS 10 29.2148 ACTB 10 17.827 11.3878 0.0003732
CAS 11 28.4687 ACTB 11 17.1318 11.3369 0.0003866
CAS 12 28.3777 ACTB 12 16.3276 12.0501 0.0002358
CAS 13 28.7063 ACTB 13 16.5664 12.1399 0.0002216
CAS 14 28.6425 ACTB 14 17.9596 10.6829 0.0006083
CAS 15 27.5959 ACTB 15 17.2943 10.3016 0.0007923
0.00004820.0003319
0.0005407 0.0001682
0.0002694 0.0000416
0.00006170.0009078
0.0012001 0.0003878
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TX Sample ID CT HKG ID CT CT 2-CT Average SEM
GHR 1 28.6422 ACTB 1 17.3359 11.3063 0.00039488
GHR 2 28.2863 ACTB 2 17.7941 10.4922 0.00069428
GHR 3 29.2296 ACTB 3 16.5536 12.676 0.00015281
GHR 4 28.8247 ACTB 4 17.2348 11.5899 0.00032441
GHR 5 29.3396 ACTB 5 16.7007 12.6389 0.00015679
GHR 6 30.4724 ACTB 6 16.3691 14.1033 0.00005682
GHR 7 29.8178 ACTB 7 16.2588 13.559 0.00008286
GHR 8 30.3612 ACTB 8 17.8703 12.4909 0.00017373
GHR 9 30.8976 ACTB 9 16.6322 14.2654 0.00005078
GHR 10 29.6507 ACTB 10 17.827 11.8237 0.00027587
GHR 11 29.1254 ACTB 11 17.1318 11.9936 0.00024523
GHR 12 31.1288 ACTB 12 16.3276 14.8012 0.00003503
GHR 13 29.2169 ACTB 13 16.5664 12.6505 0.00015553
GHR 14 29.9811 ACTB 14 17.9596 12.0215 0.00024053
GHR 15 29.6369 ACTB 15 17.2943 12.3426 0.00019253
0.00007569
0.000024600.00019620
0.00018538
0.00041399 0.00015660
0.000078070.00017934
0.00010245 0.00003682
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Appendix Table 39: Q-PCR raw CT values and calculations for IGF-I mRNA abundance 
in MEC from Jersey milk cultured for 2 d and 4 d. 
 
 
Appendix Table 40: Q-PCR raw CT values and calculations for IGFBP-3 mRNA 
abundance in MEC from Jersey milk cultured for 2 d and 4 d. 
TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGF1 1 30.715 ACTB 1 17.3359 13.3791 9.3862E-05
IGF1 2 31.6277 ACTB 2 17.7941 13.8336 6.8497E-05
IGF1 3 31.7163 ACTB 3 16.5536 15.1627 2.72629E-05
IGF1 4 31.5126 ACTB 4 17.2348 14.2778 5.03447E-05
IGF1 5 32.3723 ACTB 5 16.7007 15.6716 1.91592E-05
IGF1 6 31.8291 ACTB 6 16.3691 15.46 2.21859E-05
IGF1 7 32.3105 ACTB 7 16.2588 16.0517 1.47217E-05
IGF1 8 33.0166 ACTB 8 17.8703 15.1463 2.75746E-05
IGF1 9 31.1688 ACTB 9 16.6322 14.5366 4.20773E-05
IGF1 10 31.871 ACTB 10 17.827 14.044 5.92018E-05
IGF1 11 31.5062 ACTB 11 17.1318 14.3744 4.70841E-05
IGF1 12 32.7503 ACTB 12 16.3276 16.4227 1.13835E-05
IGF1 13 31.981 ACTB 13 16.5664 15.4146 2.28951E-05
IGF1 14 32.2579 ACTB 14 17.9596 14.2983 4.96344E-05
IGF1 15 39.0223 ACTB 15 17.2943 21.728 2.87886E-07
1.42617E-05
1.43526E-05
7.90166E-06
9.92924E-06
1.94066E-056.32073E-05
3.05633E-05
2.81245E-05
3.92231E-05
2.42725E-05
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TX Sample ID CT HKG ID CT CT 2-CT Average SEM
IGFBP3 1 20.4037 ACTB 1 17.3359 3.0678 0.119261
IGFBP3 2 20.4245 ACTB 2 17.7941 2.6304 0.161499
IGFBP3 3 20.325 ACTB 3 16.5536 3.7714 0.073231
IGFBP3 4 19.7434 ACTB 4 17.2348 2.5086 0.175726
IGFBP3 5 22.0573 ACTB 5 16.7007 5.3566 0.024406
IGFBP3 6 21.1498 ACTB 6 16.3691 4.7807 0.036380
IGFBP3 7 20.0309 ACTB 7 16.2588 3.7721 0.073196
IGFBP3 8 19.2561 ACTB 8 17.8703 1.3858 0.382677
IGFBP3 9 20.2128 ACTB 9 16.6322 3.5806 0.083586
IGFBP3 10 18.7936 ACTB 10 17.827 0.9666 0.511711
IGFBP3 11 17.2565 ACTB 11 17.1318 0.1247 0.917195
IGFBP3 12 18.3244 ACTB 12 16.3276 1.9968 0.250555
IGFBP3 13 18.1136 ACTB 13 16.5664 1.5472 0.342174
IGFBP3 14 18.0556 ACTB 14 17.9596 0.096 0.935623
IGFBP3 15 18.8973 ACTB 15 17.2943 1.603 0.329192
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0.193940
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